BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999;19:475-505. [PMID: 10643630 DOI: 10.1055/s-2007-1007133] [Cited by in Crossref: 552] [Cited by in F6Publishing: 401] [Article Influence: 25.1] [Reference Citation Analysis]
Number Citing Articles
1 D'amico G. First meta-analysis of octreotide for variceal bleeding. A lost opportunity. Journal of Hepatology 2002;36:574-7. [DOI: 10.1016/s0168-8278(02)00046-6] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
2 Abid S, Ali S, Baig MA, Waheed AA. Is it time to replace propranolol with carvedilol for portal hypertension? World J Gastrointest Endosc 2015; 7(5): 532-539 [PMID: 25992192 DOI: 10.4253/wjge.v7.i5.532] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Poza Cordon J, Froilan Torres C, Burgos García A, Gea Rodriguez F, Suárez de Parga JM. Endoscopic management of esophageal varices. Clinical manifestations and management 2012; 4(7): 312-322 [PMID: 22816012 DOI: 10.4253/wjge.v4.i7.312] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
4 Carey W. Portal hypertension: Diagnosis and management with particular reference to variceal hemorrhage: Portal hypertension. Journal of Digestive Diseases 2011;12:25-32. [DOI: 10.1111/j.1751-2980.2010.00473.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
5 Arguedas MR, Chen VK, Eloubeidi MA, Fallon MB. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol. 2003;98:679-690. [PMID: 12650806 DOI: 10.1111/j.1572-0241.2003.07327.x] [Cited by in Crossref: 188] [Cited by in F6Publishing: 153] [Article Influence: 9.9] [Reference Citation Analysis]
6 Ling SC, Walters T, McKiernan PJ, Schwarz KB, Garcia-Tsao G, Shneider BL. Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research. J Pediatr Gastroenterol Nutr. 2011;52:254-261. [PMID: 21336158 DOI: 10.1097/mpg.0b013e318205993a] [Cited by in Crossref: 74] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
7 Longacre AV, Garcia-Tsao G. A commonsense approach to esophageal varices. Clin Liver Dis. 2006;10:613-625. [PMID: 17162231 DOI: 10.1016/j.cld.2006.08.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
8 Reiberger T, Mandorfer M. Beta adrenergic blockade and decompensated cirrhosis. J Hepatol. 2017;66:849-859. [PMID: 27864004 DOI: 10.1016/j.jhep.2016.11.001] [Cited by in Crossref: 74] [Cited by in F6Publishing: 53] [Article Influence: 12.3] [Reference Citation Analysis]
9 Peñaloza-posada MA, Pérez-torres E, Pérez-hernández JL, Higuera-de la Tijera F. Non-invasive parameters as predictors of high risk of variceal bleeding in cirrhotic patients. Revista Médica Del Hospital General De México 2014;77:179-84. [DOI: 10.1016/j.hgmx.2014.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Lotfipour AK, Douek M, Shimoga SV, Sayer JW, Han SB, Jutabha R, Lu DS. The cost of screening esophageal varices: traditional endoscopy versus computed tomography. J Comput Assist Tomogr 2014;38:963-7. [PMID: 25229201 DOI: 10.1097/RCT.0000000000000147] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
11 Tseng Y, Ma L, Luo T, Zeng X, Li F, Li N, Wei Y, Chen S. Patient Response to Endoscopic Therapy for Gastroesophageal Varices Based on Endoscopic Ultrasound Findings. Gut Liver 2018;12:562-70. [PMID: 29699062 DOI: 10.5009/gnl17471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Bosch J, Dell'era A. [Vasoactive drugs for the treatment of bleeding esophageal varices]. Gastroenterol Clin Biol 2004;28 Spec No 2:B186-9. [PMID: 15150511 DOI: 10.1016/s0399-8320(04)95254-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Villanueva C, Balanzó J. Variceal Bleeding: Pharmacological Treatment and Prophylactic Strategies. Drugs 2008;68:2303-24. [DOI: 10.2165/0003495-200868160-00004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
14 de Franchis R, Dell’Era A, Primignani M. Diagnosis and monitoring of portal hypertension. Dig Liver Dis. 2008;40:312-317. [PMID: 18294933 DOI: 10.1016/j.dld.2007.12.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
15 Bosch J. Prevention of Variceal Rebleeding: Endoscopes, Drugs, and More. Hepatology 2000;32:660-2. [DOI: 10.1053/jhep.2000.16663] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
16 Villanueva C, Escorsell À. Optimizing General Management of Acute Variceal Bleeding in Cirrhosis. Curr Hepatology Rep 2014;13:198-207. [DOI: 10.1007/s11901-014-0241-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
17 Appavu SK. Mortality of Cirrhosis Induced Variceal Hemorrhage Is Declining: Can We Do More? Crit Care Med 2019;47:1453-5. [PMID: 31524694 DOI: 10.1097/CCM.0000000000003945] [Reference Citation Analysis]
18 Kim H, Choi D, Gwak GY, Lee JH, Lee SJ, Kim SH, Lee JY, Park Y, Chang I, Lim HK. High-risk esophageal varices in patients treated with locoregional therapies for hepatocellular carcinoma: evaluation with regular follow-up liver CT. Dig Dis Sci. 2009;54:2247-2252. [PMID: 19051016 DOI: 10.1007/s10620-008-0606-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
19 Gu J, Zhang Q, Xue D, Cai H, Xu L. A randomized controlled study of fuzheng huayu capsule for prevention of esophageal variceal bleeding in patients with liver cirrhosis. Evid Based Complement Alternat Med 2013;2013:534960. [PMID: 23762144 DOI: 10.1155/2013/534960] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
20 Tan H, Martin P. Care of the Liver Transplant Candidate. Clinics in Liver Disease 2011;15:779-806. [DOI: 10.1016/j.cld.2011.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Imperiale TF, Klein RW, Chalasani N. Cost-effectiveness analysis of variceal ligation vs. beta-blockers for primary prevention of variceal bleeding. Hepatology. 2007;45:870-878. [PMID: 17393528 DOI: 10.1002/hep.21605] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
22 Sussman D, Barkin JS. Band ligation versus propanolol and isosorbide mononitrate for primary prophylaxis of variceal bleeding. Am J Gastroenterol 2003;98:1887-9. [PMID: 12907349 DOI: 10.1111/j.1572-0241.2003.07623.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Lopez-mendez E, Avila-escobedo L. Pregnancy and portal hypertension a pathology view of physiologic changes. Annals of Hepatology 2006;5:219-23. [DOI: 10.1016/s1665-2681(19)32016-2] [Cited by in Crossref: 12] [Article Influence: 0.8] [Reference Citation Analysis]
24 Sarin SK, Mishra SR, Sharma P, Sharma BC, Kumar A. Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial. Hepatol Int 2013;7:248-56. [PMID: 26201639 DOI: 10.1007/s12072-012-9353-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
25 Laine L. Primary prophylaxis of esophageal variceal bleeding: an endoscopic approach. J Hepatol. 2010;52:944-945. [PMID: 20381891 DOI: 10.1016/j.jhep.2009.12.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 Gomes-Porras M, Cárdenas-Salas J, Álvarez-Escolá C. Somatostatin Analogs in Clinical Practice: a Review. Int J Mol Sci 2020;21:E1682. [PMID: 32121432 DOI: 10.3390/ijms21051682] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
27 de Franchis R, Dell'era A, Fazzini L, Zatelli S, Savojardo V, Primignani M. Evaluation and follow-up of patients with portal hypertension and oesophageal varices: how and when. Digestive and Liver Disease 2001;33:643-6. [DOI: 10.1016/s1590-8658(01)80036-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
28 Grewal P, Martin P. Care of the cirrhotic patient. Clin Liver Dis 2009;13:331-40. [PMID: 19442922 DOI: 10.1016/j.cld.2009.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
29 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clin Mol Hepatol 2020;26:83-127. [PMID: 31918536 DOI: 10.3350/cmh.2019.0010n] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
30 Wan S, Wei Y, Zhang X, Liu X, Zhang W, He Y, Yuan F, Yao S, Yue Y, Song B. Multiparametric radiomics nomogram may be used for predicting the severity of esophageal varices in cirrhotic patients. Ann Transl Med 2020;8:186. [PMID: 32309333 DOI: 10.21037/atm.2020.01.122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Mckiernan PJ. Treatment of Variceal Bleeding. Gastrointestinal Endoscopy Clinics of North America 2001;11:789-812. [DOI: 10.1016/s1052-5157(18)30047-3] [Cited by in Crossref: 28] [Article Influence: 1.3] [Reference Citation Analysis]
32 Kim YD. Management of acute variceal bleeding. Clin Endosc. 2014;47:308-314. [PMID: 25133116 DOI: 10.5946/ce.2014.47.4.308] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
33 Reynaert H, van rossen E, Uyama N, Chatterjee N, Kumar U, Urbain D, Geerts A. Expression of somatostatin receptors in splanchnic blood vessels of normal and cirrhotic rats. Liver Int 2007;27:825-31. [DOI: 10.1111/j.1478-3231.2007.01503.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
34 Bittencourt PL, Farias AQ, Strauss E, Mattos AA; Pannel of the 1st Brazilian Consensus of Variceal Bleeding, Brazilian Society of Hepatology. Variceal bleeding: consensus meeting report from the Brazilian Society of Hepatology. Arq Gastroenterol. 2010;47:202-216. [PMID: 20721469 DOI: 10.1590/s0004-28032010000200017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
35 Abraldes JG, Bosch J. The treatment of acute variceal bleeding. J Clin Gastroenterol. 2007;41 Suppl 3:S312-S317. [PMID: 17975482 DOI: 10.1097/mcg.0b013e318150d3dd] [Cited by in Crossref: 35] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
36 Klebl FH, Bregenzer N, Schöfer L, Tamme W, Langgartner J, Schölmerich J, Messmann H. Comparison of inpatient and outpatient upper gastrointestinal haemorrhage. Int J Colorectal Dis 2005;20:368-75. [PMID: 15551100 DOI: 10.1007/s00384-004-0642-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
37 Bosch J, Abraldes JG. Variceal bleeding: pharmacological therapy. Dig Dis 2005;23:18-29. [PMID: 15920322 DOI: 10.1159/000084722] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
38 D'Amico G, Pagliaro L, Pietrosi G, Tarantino I. Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients. Cochrane Database Syst Rev. 2010;CD002233. [PMID: 20238318 DOI: 10.1002/14651858.cd002233.pub2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
39 D’amico G. Esophageal varices: from appearance to rupture; natural history and prognostic indicators. In: Groszmann RJ, Bosch J, editors. Portal Hypertension in the 21st Century. Dordrecht: Springer Netherlands; 2004. pp. 147-54. [DOI: 10.1007/978-94-007-1042-9_17] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
40 Chuah YY, Hsu PI, Tsai WL, Yu HC, Tsay FW, Chen WC, Lin KH, Lee YY, Wang HM. Short-term vasoactive agent treatment driven by physicians' preference in acute esophageal variceal bleeding in a tertiary center. PeerJ 2019;7:e7913. [PMID: 31720102 DOI: 10.7717/peerj.7913] [Reference Citation Analysis]
41 Scheiner B, Parada-Rodriguez D, Bucsics T, Schwabl P, Mandorfer M, Pfisterer N, Riedl F, Sieghart W, Ferlitsch A, Trauner M, Peck-Radosavljevic M, Reiberger T. Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices. Scand J Gastroenterol 2017;52:1008-15. [PMID: 28532189 DOI: 10.1080/00365521.2017.1329456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
42 Dulger AC, Kemik O, Begenik H, Sumer A, Bulut D, Bulut G. Synchronous Esophageal Squamous Cell Carcinoma and Esophageal Variceal Bleeding due to Idiopathic Portal Hypertension: A Case Report. Gastroenterology Res 2011;4:84-7. [PMID: 27942320 DOI: 10.4021/gr300e] [Reference Citation Analysis]
43 Lui HF, Stanley AJ, Forrest EH, Jalan R, Hislop WS, Mills PR, Finlayson ND, Macgilchrist AJ, Hayes PC. Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology 2002;123:735-44. [PMID: 12198700 DOI: 10.1053/gast.2002.35385] [Cited by in Crossref: 138] [Cited by in F6Publishing: 100] [Article Influence: 6.9] [Reference Citation Analysis]
44 Kamal A, Abd Elmoety AA, Hamza Y, Zeid A. Endoscopic Variceal Ligation followed by Argon Plasma Coagulation Against Endoscopic Variceal Ligation Alone: A Randomized Controlled Trial. J Clin Gastroenterol. 2017;51:49-55. [PMID: 27136962 DOI: 10.1097/mcg.0000000000000535] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
45 Bosch J, Garcia-tsao G. Pharmacological versus endoscopic therapy in the prevention of variceal hemorrhage: And the winner is…. Hepatology 2009;50:674-7. [DOI: 10.1002/hep.23164] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
46 Zanetto A, Shalaby S, Feltracco P, Gambato M, Germani G, Russo FP, Burra P, Senzolo M. Recent Advances in the Management of Acute Variceal Hemorrhage. J Clin Med 2021;10:3818. [PMID: 34501265 DOI: 10.3390/jcm10173818] [Reference Citation Analysis]
47 Garcia-tsao G. Portal hypertension: . Current Opinion in Gastroenterology 2001;17:281-90. [DOI: 10.1097/00001574-200105000-00012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
48 Nietsch HH. Management of Portal Hypertension: . Journal of Clinical Gastroenterology 2005;39:232-6. [DOI: 10.1097/01.mcg.0000152783.22266.35] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
49 Miyaaki H, Ichikawa T, Taura N, Miuma S, Isomoto H, Nakao K. Endoscopic management of esophagogastric varices in Japan. Ann Transl Med. 2014;2:42. [PMID: 25333017 DOI: 10.3978/j.issn.2305-5839.2014.05.02] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
50 Abraldes JG, Sarlieve P, Tandon P. Measurement of portal pressure. Clin Liver Dis. 2014;18:779-792. [PMID: 25438283 DOI: 10.1016/j.cld.2014.07.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
51 Piyachaturawat P, Siramolpiwat S, Sonsiri K, Tangkijvanich P, Treeprasertsuk S. Changes in transient elastography in early cirrhotic patients after receiving nonselective B-blocker for primary variceal bleeding prophylaxis: Three-month follow up. JGH Open 2018;2:172-7. [PMID: 30483585 DOI: 10.1002/jgh3.12063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Bosch J. Is treatment with nadolol effective against the growth of small esophageal varices in patients with cirrhosis? Nat Clin Pract Gastroenterol Hepatol 2005;2:18-9. [PMID: 16265094 DOI: 10.1038/ncpgasthep0063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
53 Groszmann RJ, Garcia-tsao G. Endoscopic variceal banding vs. pharmacological therapy for the prevention of recurrent variceal hemorrhage: What makes the difference? Gastroenterology 2002;123:1388-91. [DOI: 10.1053/gast.2002.36364] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
54 D’Amico G. The role of vasoactive drugs in the treatment of oesophageal varices. Expert Opin Pharmacother. 2004;5:349-360. [PMID: 14996631 DOI: 10.1517/14656566.5.2.349] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
55 Spiegel BM, Targownik L, Dulai GS, Karsan HA, Gralnek IM. Endoscopic screening for esophageal varices in cirrhosis: Is it ever cost effective? Hepatology. 2003;37:366-377. [PMID: 12540787 DOI: 10.1053/jhep.2003.50050] [Cited by in Crossref: 97] [Cited by in F6Publishing: 77] [Article Influence: 5.1] [Reference Citation Analysis]
56 Cross T, Antoniades C, Harrison P. Non-invasive markers for the prediction of fibrosis in chronic hepatitis C infection. Hepatol Res 2008;38:762-9. [PMID: 18462378 DOI: 10.1111/j.1872-034X.2008.00364.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
57 Villanueva C, Colomo A, Aracil C, Guarner C. Current endoscopic therapy of variceal bleeding. Best Pract Res Clin Gastroenterol. 2008;22:261-278. [PMID: 18346683 DOI: 10.1016/j.bpg.2007.11.012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
58 Isfordink CJ, Maan R, de Man RA, van Erpecum KJ, van der Meer AJ. Should we continue surveillance for hepatocellular carcinoma and gastroesophageal varices in patients with cirrhosis and cured HCV infection? Eur J Intern Med 2021:S0953-6205(21)00296-X. [PMID: 34563447 DOI: 10.1016/j.ejim.2021.08.023] [Reference Citation Analysis]
59 Gana JC, Valentino PL, Morinville V, O'connor C, Ling SC. Variation in Care for Children With Esophageal Varices: A Study of Physicians', Patients', and Families' Approaches and Attitudes. Journal of Pediatric Gastroenterology & Nutrition 2011;52:751-5. [DOI: 10.1097/mpg.0b013e318213be81] [Cited by in Crossref: 37] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
60 Kodama H, Aikata H, Takaki S, Azakami T, Katamura Y, Kawaoka T, Hiramatsu A, Waki K, Imamura M, Kawakami Y, Takahashi S, Toyota N, Ito K, Chayama K. Evaluation of portosystemic collaterals by MDCT-MPR imaging for management of hemorrhagic esophageal varices. European Journal of Radiology 2010;76:239-45. [DOI: 10.1016/j.ejrad.2009.06.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
61 Escorsell À, Bañares R, García-pagán JC, Gilabert R, Moitinho E, Piqueras B, Bru C, Echenagusia A, Granados A, Bosch J. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: A randomized controlled trial: TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: A randomized controlled trial. Hepatology 2002;35:385-92. [DOI: 10.1053/jhep.2002.30418] [Cited by in Crossref: 162] [Cited by in F6Publishing: 116] [Article Influence: 8.5] [Reference Citation Analysis]
62 Fontana RJ, Everson GT, Tuteja S, Vargas HE, Shiffman ML. Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis. Clinical Gastroenterology and Hepatology 2004;2:183-97. [DOI: 10.1016/s1542-3565(04)00002-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
63 Albillos A, Bañares R, González M, Ripoll C, Gonzalez R, Catalina MV, Molinero LM. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis. Am J Gastroenterol 2007;102:1116-26. [PMID: 17391317 DOI: 10.1111/j.1572-0241.2007.01191.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 75] [Article Influence: 6.4] [Reference Citation Analysis]
64 Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65:310-335. [PMID: 27786365 DOI: 10.1002/hep.28906] [Cited by in Crossref: 713] [Cited by in F6Publishing: 537] [Article Influence: 118.8] [Reference Citation Analysis]
65 Garcia-pagan JC. Non-selective beta-blockers in the prevention of first variceal bleeding. Is there any definite alternative? Journal of Hepatology 2002;37:393-5. [DOI: 10.1016/s0168-8278(02)00244-1] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
66 Maruyama H, Kondo T, Sekimoto T, Kiyono S, Shimada T, Takahashi M, Okugawa H, Yokosuka O. Hyponatremia: a significant factor in a poor prognosis for cirrhosis with Child A/B after variceal eradication. J Hepatobiliary Pancreat Sci 2015;22:771-8. [PMID: 26202665 DOI: 10.1002/jhbp.282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
67 Jachs M, Reiberger T. Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored Approach. Clin Liver Dis 2021;25:311-26. [PMID: 33838852 DOI: 10.1016/j.cld.2021.01.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Kadam JS, Talal AH. Changing treatment paradigms: hepatitis C virus in HIV-infected patients. AIDS Patient Care STDS 2007;21:154-68. [PMID: 17428183 DOI: 10.1089/apc.2006.0126] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
69 Laleman W, Landeghem L, Wilmer A, Fevery J, Nevens F. Portal hypertension: from pathophysiology to clinical practice. Liver Int 2005;25:1079-90. [PMID: 16343056 DOI: 10.1111/j.1478-3231.2005.01163.x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 5.1] [Reference Citation Analysis]
70 Kazemi F, Kettaneh A, N’kontchou G, Pinto E, Ganne-carrie N, Trinchet J, Beaugrand M. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. Journal of Hepatology 2006;45:230-5. [DOI: 10.1016/j.jhep.2006.04.006] [Cited by in Crossref: 272] [Cited by in F6Publishing: 246] [Article Influence: 17.0] [Reference Citation Analysis]
71 Rockey DC, Bissell DM. Noninvasive measures of liver fibrosis. Hepatology 2006;43:S113-20. [DOI: 10.1002/hep.21046] [Cited by in Crossref: 221] [Cited by in F6Publishing: 210] [Article Influence: 13.8] [Reference Citation Analysis]
72 Mandorfer M, Bota S, Schwabl P, Bucsics T, Pfisterer N, Kruzik M, Hagmann M, Blacky A, Ferlitsch A, Sieghart W. Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology. 2014;146:1680-1690.e1. [PMID: 24631577 DOI: 10.1053/j.gastro.2014.03.005] [Cited by in Crossref: 245] [Cited by in F6Publishing: 177] [Article Influence: 30.6] [Reference Citation Analysis]
73 Merkel C. Nonselective β-blockers plus nitrates in portal hypertension: An open question. Hepatology 2003;37:1254-6. [DOI: 10.1053/jhep.2003.50274] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
74 Hidaka H, Kokubu S, Nakazawa T, Okuwaki Y, Ono K, Watanabe M, Shibuya A, Saigenji K. New angiotensin II type 1 receptor blocker olmesartan improves portal hypertension in patients with cirrhosis. Hepatol Res 2007;37:1011-7. [PMID: 17608670 DOI: 10.1111/j.1872-034X.2007.00165.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Wang S, Xiao M, Hua L, Jia Y, Chen S, Zhang K. Endoscopic therapy for gastro-oesophageal varices of Caroli's syndrome: a case report. J Int Med Res 2020;48:300060519877993. [PMID: 31594447 DOI: 10.1177/0300060519877993] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
76 Zargar SA, Yattoo GN, Javid G, Khan BA, Shah AH, Shah NA, Gulzar GM, Singh J, Shafi HM. Fifteen-year follow up of endoscopic injection sclerotherapy in children with extrahepatic portal venous obstruction. J Gastroenterol Hepatol 2004;19:139-45. [PMID: 14731122 DOI: 10.1111/j.1440-1746.2004.03224.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
77 Ertel AE, Chang AL, Kim Y, Shah SA. Management of gastrointestinal bleeding in patients with cirrhosis. Curr Probl Surg 2016;53:366-95. [PMID: 27585818 DOI: 10.1067/j.cpsurg.2016.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
78 Tomikawa M, Akahoshi T, Sugimachi K, Ikeda Y, Korenaga D, Takenaka K, Hashizume M, Maehara Y. An assessment of surgery for portal hypertensive patients performed at a single community hospital. Surg Today 2010;40:620-5. [PMID: 20582512 DOI: 10.1007/s00595-009-4123-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
79 Escorsell A, Bosch J. Pathophysiology of variceal bleeding. In: Groszmann RJ, Bosch J, editors. Portal Hypertension in the 21st Century. Dordrecht: Springer Netherlands; 2004. pp. 155-66. [DOI: 10.1007/978-94-007-1042-9_18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
80 Aref S, Abdel-Khalek EE, Abdel-Aal IA, Refaie ME. Circadian pattern of acute variceal bleeding among cirrhotic Egyptian patients. Indian J Hematol Blood Transfus 2009;25:53-8. [PMID: 23100976 DOI: 10.1007/s12288-009-0014-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
81 Hidaka H, Tanabe S, Uojima H, Shao X, Iwasaki S, Wada N, Kubota K, Tanaka Y, Nakazawa T, Shibuya A, Kokubu S, Koizumi W. Long-term observation in patients with esophageal varices after endoscopic variceal ligation accompanied with 24-hour pH monitoring. Hepatol Res 2020;50:1255-63. [PMID: 32838474 DOI: 10.1111/hepr.13562] [Reference Citation Analysis]
82 Penrice DD, Shah S, Kezer CA, Peeraphatdit TB, Sanyal AJ, Davis B, Mara KC, Shah VH, Kamath PS, Simonetto DA. Risk Prediction of Nosocomial and Posthospital Discharge Infections in Alcohol-Associated Hepatitis. Hepatol Commun 2021. [PMID: 34558860 DOI: 10.1002/hep4.1786] [Reference Citation Analysis]
83 Rahimi RS, Guntipalli P, Rockey DC. Worldwide practices for pharmacologic therapy in esophageal variceal hemorrhage. Scand J Gastroenterol 2014;49:131-7. [PMID: 24295524 DOI: 10.3109/00365521.2013.850736] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
84 Hwang JH, Shergill AK, Acosta RD, Chandrasekhara V, Chathadi KV, Decker GA, Early DS, Evans JA, Fanelli RD, Fisher DA, Foley KQ, Fonkalsrud L, Jue T, Khashab MA, Lightdale JR, Muthusamy VR, Pasha SF, Saltzman JR, Sharaf R, Cash BD; American Society for Gastrointestinal Endoscopy. The role of endoscopy in the management of variceal hemorrhage. Gastrointest Endosc. 2014;80:221-227. [PMID: 25034836 DOI: 10.1016/j.gie.2013.07.023] [Cited by in Crossref: 113] [Cited by in F6Publishing: 80] [Article Influence: 16.1] [Reference Citation Analysis]
85 Zia HA, Aby ES, Rabiee A. An Update on the Management of Esophageal Variceal Hemorrhage. Clin Liver Dis (Hoboken) 2021;18:179-83. [PMID: 34745574 DOI: 10.1002/cld.1108] [Reference Citation Analysis]
86 Pfisterer N, Unger LW, Reiberger T. Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis. World J Hepatol 2021; 13(7): 731-746 [PMID: 34367495 DOI: 10.4254/wjh.v13.i7.731] [Reference Citation Analysis]
87 Bosch J, Abraldes JG, Groszmann R. Current management of portal hypertension. J Hepatol. 2003;38 Suppl 1:S54-S68. [PMID: 12591186 DOI: 10.1016/s0168-8278(02)00430-0] [Cited by in Crossref: 182] [Cited by in F6Publishing: 38] [Article Influence: 9.6] [Reference Citation Analysis]
88 Toubia N, Sanyal AJ. Portal hypertension and variceal hemorrhage. Med Clin North Am. 2008;92:551-574, viii. [PMID: 18387376 DOI: 10.1016/j.mcna.2007.12.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
89 Hobolth L, Krag A, Malchow-Møller A, Gancho V, Jensen S, Møller S, Bendtsen F. Adherence to guidelines in bleeding oesophageal varices and effects on outcome: comparison between a specialized unit and a community hospital. Eur J Gastroenterol Hepatol 2010;22:1221-7. [PMID: 20848694 DOI: 10.1097/meg.0b013e32833aa15f] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
90 Björnsson E, Björnsson E, Aabakken L, Olafsson S, Bendtsen F. Are specific guidelines necessary for treatment of esophageal varices in the Nordic countries? Scandinavian Journal of Gastroenterology 2009;44:1037-47. [DOI: 10.1080/00365520903075170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
91 Boyer TD. Primary prophylaxis for variceal bleeding: are we there yet? Gastroenterology 2005;128:1120-2. [PMID: 15825093 DOI: 10.1053/j.gastro.2005.02.035] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
92 Gana JC, Turner D, Yap J, Adams-webber T, Rashkovan N, Ling SC, Gana JC. Platelet count, spleen length, and platelet count/spleen length ratio for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd008759] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
93 Sharma P, Rakela J. Management of pre-liver transplantation patient?Part 2. Liver Transpl 2005;11:249-60. [DOI: 10.1002/lt.20379] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
94 Mogilevets EV, Vorobey AV, Garelik PV. [Prognosis of bleeding recurrence after endoscopic sclerotherapy of esophageal varices]. Khirurgiia (Mosk) 2020;:60-7. [PMID: 33047587 DOI: 10.17116/hirurgia202010160] [Reference Citation Analysis]
95 Di Pascoli L, Buja A, Bolognesi M, Montagnese S, Gatta A, Gregori D, Merkel C. Cost-effectiveness analysis of beta-blockers vs endoscopic surveillance in patients with cirrhosis and small varices. World J Gastroenterol 2014; 20(30): 10464-10469 [PMID: 25132763 DOI: 10.3748/wjg.v20.i30.10464] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
96 Yachha SK, Chetri K, Lal R. Management of portal hypertension. Indian J Pediatr 2002;69:809-13. [PMID: 12420915 DOI: 10.1007/BF02723696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
97 Toshikuni N, Takuma Y, Tsutsumi M. Management of gastroesophageal varices in cirrhotic patients: current status and future directions. Ann Hepatol 2016;15:314-25. [PMID: 27049485 DOI: 10.5604/16652681.1198800] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
98 Lee HL, Han DS, Kim JB, Jeon YC, Sohn JH, Hahm JS. Successful treatment of protein-losing enteropathy induced by intestinal lymphangiectasia in a liver cirrhosis patient with octreotide: a case report. J Korean Med Sci. 2004;19:466-469. [PMID: 15201518 DOI: 10.3346/jkms.2004.19.3.466] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
99 Bellot P, García-Pagán JC, Abraldes JG, Bosch J. Primary prophylaxis of esophageal variceal bleeding in cirrhosis. Gastroenterol Clin Biol. 2008;32:532-540. [PMID: 18456445 DOI: 10.1016/j.gcb.2008.03.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
100 Cerqueira RM, Andrade L, Correia MR, Fernandes CD, Manso MC. Risk factors for in-hospital mortality in cirrhotic patients with oesophageal variceal bleeding. Eur J Gastroenterol Hepatol 2012;24:551-7. [PMID: 22356784 DOI: 10.1097/MEG.0b013e3283510448] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
101 Bosch J. Portal Hypertension and Cirrhosis: From Evolving Concepts to Better Therapies. Clin Liver Dis (Hoboken) 2020;15:S8-S12. [PMID: 32140209 DOI: 10.1002/cld.844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
102 Mandorfer M, Hernández-gea V, Reiberger T, García-pagán JC. Hepatic Venous Pressure Gradient Response in Non-Selective Beta-Blocker Treatment—Is It Worth Measuring? Curr Hepatology Rep 2019;18:174-86. [DOI: 10.1007/s11901-019-00469-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
103 Gluud LL, Morgan MY; Cochrane Hepato-Biliary Group. Endoscopic therapy and beta-blockers for secondary prevention in adults with cirrhosis and oesophageal varices. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd012694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
104 Liou IW. Management of end-stage liver disease. Med Clin North Am. 2014;98:119-152. [PMID: 24266918 DOI: 10.1016/j.mcna.2013.09.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
105 Comar KM, Sanyal AJ. Portal hypertensive bleeding. Gastroenterology Clinics of North America 2003;32:1079-105. [DOI: 10.1016/s0889-8553(03)00099-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
106 Cat TB, Liu-DeRyke X. Medical management of variceal hemorrhage. Crit Care Nurs Clin North Am. 2010;22:381-393. [PMID: 20691388 DOI: 10.1016/j.ccell.2010.02.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
107 Garcia-pagán JC, Bosch J. Endoscopic band ligation in the treatment of portal hypertension. Nat Rev Gastroenterol Hepatol 2005;2:526-35. [DOI: 10.1038/ncpgasthep0323] [Cited by in Crossref: 101] [Cited by in F6Publishing: 74] [Article Influence: 5.9] [Reference Citation Analysis]
108 Yim SY, Seo YS, Jung CH, Kim TH, Kim ES, Keum B, Kim JH, An H, Yim HJ, Yeon JE, Jeen YT, Lee HS, Chun HJ, Byun KS, Um SH, Kim CD, Ryu HS. Risk Factors for Developing Hyponatremia during Terlipressin Treatment: A Retrospective Analyses in Variceal Bleeding. J Clin Gastroenterol. 2015;49:607-612. [PMID: 25216384 DOI: 10.1097/mcg.0000000000000217] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
109 Sarin SK, Wadhawan M, Agarwal SR, Tyagi P, Sharma BC. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol. 2005;100:797-804. [PMID: 15784021 DOI: 10.1111/j.1572-0241.2005.40468.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 81] [Article Influence: 6.2] [Reference Citation Analysis]
110 D'amico G, Pagliaro L, Pietrosi G, Tarantino I, D'amico G. Emergency sclerotherapy versus medical interventions for bleeding oesophageal varices in cirrhotic patients. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd002233] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
111 Bultas AC, Teshome B, Richter SK, Schafers S, Cooke E, Call WB. Use of Nonselective β-Blockers in Patients With End-Stage Liver Disease and Select Complications. Ann Pharmacother 2020;54:583-93. [DOI: 10.1177/1060028019893092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
112 Burza MA, Marschall HU, Napoleone L, Molinaro A. The 35-year odyssey of beta blockers in cirrhosis: any gender difference in sight? Pharmacol Res 2017;119:20-6. [PMID: 28099882 DOI: 10.1016/j.phrs.2017.01.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
113 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-460. [PMID: 29653741 DOI: 10.1016/j.jhep.2018.03.024] [Cited by in Crossref: 660] [Cited by in F6Publishing: 520] [Article Influence: 165.0] [Reference Citation Analysis]
114 Shalimar, Vaishnav M, Elhence A, Kumar R, Mohta S, Palle C, Kumar P, Ranjan M, Vajpai T, Prasad S, Yegurla J, Dhooria A, Banyal V, Agarwal S, Bansal R, Bhattacharjee S, Aggarwal R, Soni KD, Rudravaram S, Singh AK, Altaf I, Choudekar A, Mahapatra SJ, Gunjan D, Kedia S, Makharia G, Trikha A, Garg P, Saraya A. Outcome of Conservative Therapy in Coronavirus disease-2019 Patients Presenting With Gastrointestinal Bleeding. J Clin Exp Hepatol 2021;11:327-33. [PMID: 33519132 DOI: 10.1016/j.jceh.2020.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
115 Norberto L, Polese L, Cillo U, Grigoletto F, Burroughs AK, Neri D, Zanus G, Boccagni P, Burra P, D'amico DF. A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. Liver Transpl 2007;13:1272-8. [DOI: 10.1002/lt.21083] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
116 Sarin SK, Kumar A, Angus PW, Baijal SS, Chawla YK, Dhiman RK, Janaka de Silva H, Hamid S, Hirota S, Hou MC. Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver. Hepatol Int. 2008;2:429-439. [PMID: 19669318 DOI: 10.1007/s12072-008-9096-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
117 Arguedas MR, Heudebert GR, Eloubeidi MA, Abrams GA, Fallon MB. Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices. Am J Gastroenterol. 2002;97:2441-2452. [PMID: 12358270 DOI: 10.1111/j.1572-0241.2002.06000.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
118 Reynaert H, Vaeyens F, Qin H, Hellemans K, Chatterjee N, Winand D, Quartier E, Schuit F, Urbain D, Kumar U. Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1. Gastroenterology. 2001;121:915-930. [PMID: 11606505 DOI: 10.1053/gast.2001.27971] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 2.2] [Reference Citation Analysis]
119 Bendtsen F, Møller S, Krag A. Variceal Rebleeding: Drugs, Endoscopy or Both. In: de Franchis R, Dell’era A, editors. Variceal Hemorrhage. New York: Springer; 2014. pp. 213-28. [DOI: 10.1007/978-1-4939-0002-2_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
120 Luketic VA. MANAGEMENT OF PORTAL HYPERTENSION AFTER VARICEAL HEMORRHAGE. Clinics in Liver Disease 2001;5:677-707. [DOI: 10.1016/s1089-3261(05)70188-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
121 de Mattos ÂZ, Terra C, Farias AQ, Bittencourt PL, Alliance of Brazilian Centers for Cirrhosis Care–the ABC Group. Primary prophylaxis of variceal bleeding in patients with cirrhosis: A comparison of different strategies. World J Gastrointest Endosc 2021; 13(12): 628-637 [DOI: 10.4253/wjge.v13.i12.628] [Reference Citation Analysis]
122 Blasco-Algora S, Masegosa-Ataz J, Alonso S, Gutiérrez ML, Fernández-Rodriguez C. Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function. BMJ Open Gastroenterol 2016;3:e000104. [PMID: 28074149 DOI: 10.1136/bmjgast-2016-000104] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
123 Selby PJ, Banks RE, Gregory W, Hewison J, Rosenberg W, Altman DG, Deeks JJ, Mccabe C, Parkes J, Sturgeon C, Thompson D, Twiddy M, Bestall J, Bedlington J, Hale T, Dinnes J, Jones M, Lewington A, Messenger MP, Napp V, Sitch A, Tanwar S, Vasudev NS, Baxter P, Bell S, Cairns DA, Calder N, Corrigan N, Del Galdo F, Heudtlass P, Hornigold N, Hulme C, Hutchinson M, Lippiatt C, Livingstone T, Longo R, Potton M, Roberts S, Sim S, Trainor S, Welberry Smith M, Neuberger J, Thorburn D, Richardson P, Christie J, Sheerin N, Mckane W, Gibbs P, Edwards A, Soomro N, Adeyoju A, Stewart GD, Hrouda D. Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT. Programme Grants Appl Res 2018;6:1-528. [DOI: 10.3310/pgfar06030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
124 Osman D, Djibré M, Da Silva D, Goulenok C. Management by the intensivist of gastrointestinal bleeding in adults and children. Ann Intensive Care. 2012;2:46. [PMID: 23140348 DOI: 10.1186/2110-5820-2-46] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
125 Meng Q, Dang X, Li L, Liu Z, Li L, Wang H. Severe hyponatraemia with neurological manifestations in patients treated with terlipressin: Two case reports. J Clin Pharm Ther 2019;44:981-4. [PMID: 31421059 DOI: 10.1111/jcpt.13031] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
126 Marrero JA, Scheiman JM. Prevention of recurrent variceal bleeding: As easy as A.P.C.? Gastrointestinal Endoscopy 2002;56:600-3. [DOI: 10.1016/s0016-5107(02)70462-8] [Cited by in Crossref: 8] [Article Influence: 0.4] [Reference Citation Analysis]
127 Suk KT, Kim DJ. Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement. World J Hepatol 2015; 7(3): 607-615 [PMID: 25848485 DOI: 10.4254/wjh.v7.i3.607] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
128 Flores-calderón J, Morán-villota S, Rouassant S, Nares-cisneros J, Zárate-mondragón F, González-ortiz B, Chávez-barrera JA, Vázquez-frías R, Martínez-marín EJ, Marín-rentería N, Bojórquez-ramos MDC, De León YAC, Ortiz-galván RC, Varela-fascinetto G. Guidelines for the diagnosis and treatment of extrahepatic portal vein obstruction (EHPVO) in children. Annals of Hepatology 2013;12:S3-S24. [DOI: 10.1016/s1665-2681(19)31403-6] [Cited by in Crossref: 6] [Article Influence: 0.7] [Reference Citation Analysis]
129 Yu NC, Margolis D, Hsu M, Raman SS, Lu DS. Detection and grading of esophageal varices on liver CT: comparison of standard and thin-section multiplanar reconstructions in diagnostic accuracy. AJR Am J Roentgenol. 2011;197:643-649. [PMID: 21862806 DOI: 10.2214/ajr.10.5458] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
130 Lee CH. [Prevention of esophageal variceal bleeding]. Korean J Gastroenterol 2010;56:155-67. [PMID: 20847606 DOI: 10.4166/kjg.2010.56.3.155] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
131 Vuachet D, Cervoni J, Vuitton L, Weil D, Dritsas S, Dussaucy A, Koch S, Di Martino V, Thevenot T. Improved survival of cirrhotic patients with variceal bleeding over the decade 2000–2010. Clinics and Research in Hepatology and Gastroenterology 2015;39:59-67. [DOI: 10.1016/j.clinre.2014.06.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
132 Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W;  Practice Guidelines Committee of the American Association for the Study of Liver Diseases;  Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922-938. [PMID: 17879356 DOI: 10.1002/hep.21907] [Cited by in Crossref: 1135] [Cited by in F6Publishing: 905] [Article Influence: 75.7] [Reference Citation Analysis]
133 Turon F, Casu S, Hernández-gea V, Garcia-pagán JC. Variceal and other portal hypertension related bleeding. Best Practice & Research Clinical Gastroenterology 2013;27:649-64. [DOI: 10.1016/j.bpg.2013.08.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
134 Gunarathne LS, Rajapaksha H, Shackel N, Angus PW, Herath CB. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics. World J Gastroenterol 2020; 26(40): 6111-6140 [PMID: 33177789 DOI: 10.3748/wjg.v26.i40.6111] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
135 Villanueva C, Aracil C, Colomo A, Lopez-Balaguer JM, Piqueras M, Gonzalez B, Torras X, Guarner C, Balanzo J. Clinical trial: A randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy. Aliment Pharmacol Ther. 2009;29:397-408. [PMID: 19006538 DOI: 10.1111/j.1365-2036.2008.03880.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
136 Rockey DC. Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices. Curr Gastroenterol Rep 2006;8:7-13. [PMID: 16510029 DOI: 10.1007/s11894-006-0058-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
137 Moctezuma-Velazquez C, Kalainy S, Abraldes JG. Beta-blockers in patients with advanced liver disease: Has the dust settled? Liver Transpl. 2017;23:1058-1069. [PMID: 28590564 DOI: 10.1002/lt.24794] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
138 Santos MM, Tolentino LH, Rodrigues RA, Nakao FS, Rohr MR, de Paulo GA, Kondo M, Ferrari AP, Libera ED. Endoscopic treatment of esophageal varices in advanced liver disease patients: band ligation versus cyanoacrylate injection. Eur J Gastroenterol Hepatol. 2011;23:60-65. [PMID: 21084988 DOI: 10.1097/meg.0b013e3283415986] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
139 Bolognesi M, Balducci G, Garcia-tsao G, Gatta A, Gines P, Merli M, Rodes J, Stiegmann GV. Session 8 - Complications in the Medical Treatment of Portal Hypertension. In: de Franchis R, editor. Portal Hypertension III: Proceedings of the Third Baverno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford: Blackwell Science Ltd; 2001. pp. 180-203. [DOI: 10.1002/9780470760154.ch12] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
140 Maruyama H, Kobayashi K, Kiyono S, Ogasawara S, Ooka Y, Suzuki E, Chiba T, Kato N. Left gastric vein-based noninvasive test for esophageal varices: a same-day comparison of portal hemodynamic assessment with endoscopic appearance. Clin Transl Gastroenterol 2018;9:154. [PMID: 29795388 DOI: 10.1038/s41424-018-0021-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
141 Jafar W, Jafar AJN, Sharma A. Upper gastrointestinal haemorrhage: an update. Frontline Gastroenterol 2016;7:32-40. [PMID: 28839832 DOI: 10.1136/flgastro-2014-100492] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
142 Wilbur K, Sidhu K. Beta Blocker Prophylaxis for Patients With Variceal Hemorrhage. Journal of Clinical Gastroenterology 2005;39:435-40. [DOI: 10.1097/01.mcg.0000159222.16032.98] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
143 Abraldes JG, Angermayr B, Bosch J. The management of portal hypertension. Clin Liver Dis 2005;9:685-713, vii. [PMID: 16207571 DOI: 10.1016/j.cld.2005.08.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
144 Levy C, Zein CO, Gomez J, Soldevila–pico C, Firpi R, Morelli G, Nelson D. Prevalence and Predictors of Esophageal Varices in Patients With Primary Biliary Cirrhosis. Clinical Gastroenterology and Hepatology 2007;5:803-8. [DOI: 10.1016/j.cgh.2007.02.031] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
145 de Franchis R. Somatostatin, somatostatin analogues and other vasoactive drugs in the treatment of bleeding oesophageal varices. Dig Liver Dis. 2004;36:S93-100. [PMID: 15077917 DOI: 10.1016/j.dld.2003.11.017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
146 Farber E, Fischer D, Eliakim R, Beck-razi N, Engel A, Veitsman E, Chermesh I, Yassin K, Gaitini D, Libes M, Linn S, Soboh S, Baruch Y. Esophageal Varices: Evaluation with Esophagography with Barium versus Endoscopic Gastroduodenoscopy in Patients with Compensated Cirrhosis—Blinded Prospective Study. Radiology 2005;237:535-40. [DOI: 10.1148/radiol.2372041631] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
147 Pradhan F, Hughes D, Narasimhan RA. Management of Upper Gastrointestinal Bleeding. Hospital Medicine Clinics 2017;6:261-82. [DOI: 10.1016/j.ehmc.2016.11.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
148 Zaman A, Chalasani N. Bleeding caused by portal hypertension. Gastroenterol Clin North Am 2005;34:623-42. [PMID: 16303574 DOI: 10.1016/j.gtc.2005.08.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
149 Hicken BL, Sharara AI, Abrams GA, Eloubeidi M, Fallon MB, Arguedas MR. Hepatic venous pressure gradient measurements to assess response to primary prophylaxis in patients with cirrhosis: a decision analytical study: HVPG MEASUREMENTS TO GUIDE PRIMARY PROPHYLAXIS. Alimentary Pharmacology & Therapeutics 2003;17:145-53. [DOI: 10.1046/j.1365-2036.2003.01391.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
150 D'Amico M, Berzigotti A, Garcia-Pagan JC. Refractory acute variceal bleeding: what to do next?Clin Liver Dis. 2010;14:297-305. [PMID: 20682236 DOI: 10.1016/j.cld.2010.03.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
151 Cárdenas A, Fernández-simon A, Escorcell A. Endoscopic Band Ligation and Esophageal Stents for Acute Variceal Bleeding. Clinics in Liver Disease 2014;18:793-808. [DOI: 10.1016/j.cld.2014.07.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
152 Yan K, Bridges JF, Augustin S, Laine L, Garcia-Tsao G, Fraenkel L. Factors impacting physicians' decisions to prevent variceal hemorrhage. BMC Gastroenterol 2015;15:55. [PMID: 25934271 DOI: 10.1186/s12876-015-0287-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
153 Chawla S, Katz A, Attar BM, Gupta A, Sandhu DS, Agarwal R. Platelet count/spleen diameter ratio to predict the presence of esophageal varices in patients with cirrhosis: a systematic review. Eur J Gastroenterol Hepatol. 2012;24:431-436. [PMID: 22410714 DOI: 10.1097/meg.0b013e3283505015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
154 Lowe RC, Grace ND. Pharmacologic therapy for portal hyper-tension. Curr Gastroenterol Rep. 2001;3:24-29. [PMID: 11177691 DOI: 10.1007/s11894-001-0037-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
155 Bae J, Sinn DH, Kang W, Gwak GY, Choi MS, Paik YH, Lee JH, Koh KC, Paik SW. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy. Liver Int. 2018;38:1442-1448. [PMID: 29495113 DOI: 10.1111/liv.13732] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 9.8] [Reference Citation Analysis]
156 Bari K, Garcia-Tsao G. Treatment of portal hypertension. World J Gastroenterol 2012; 18(11): 1166-1175 [PMID: 22468079 DOI: 10.3748/wjg.v18.i11.1166] [Cited by in CrossRef: 81] [Cited by in F6Publishing: 70] [Article Influence: 8.1] [Reference Citation Analysis]
157 Gattini D, Cifuentes LI, Torres-Robles R, Gana JC. Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. Cochrane Database Syst Rev 2020;1:CD011659. [PMID: 31922266 DOI: 10.1002/14651858.CD011659.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
158 Miñano C, Garcia-Tsao G. Clinical pharmacology of portal hypertension. Gastroenterol Clin North Am 2010;39:681-95. [PMID: 20951924 DOI: 10.1016/j.gtc.2010.08.015] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
159 Kim YJ, Raman SS, Yu NC, To'o KJ, Jutabha R, Lu DS. Esophageal varices in cirrhotic patients: evaluation with liver CT. AJR Am J Roentgenol. 2007;188:139-144. [PMID: 17179356 DOI: 10.2214/ajr.05.1737] [Cited by in Crossref: 68] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
160 Moitinho E, Planas R, Banares R, Albillos A, Ruiz-del-Arbol L, Galvez C, Bosch J; Vaticeal Bleeding Study Group. Multicenter randomized controlled trial comparing different schedules of sonatostatin in the treatment of acute variceal bleeding. J Hepatol. 2001;35:712-718. [PMID: 11738097 DOI: 10.1016/S0168-8278(01)00206-9] [Cited by in Crossref: 104] [Cited by in F6Publishing: 11] [Article Influence: 5.2] [Reference Citation Analysis]
161 Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology. 2002;122:1620-1630. [PMID: 12016427 DOI: 10.1053/gast.2002.33419] [Cited by in Crossref: 152] [Cited by in F6Publishing: 127] [Article Influence: 7.6] [Reference Citation Analysis]
162 Moodley J, Lopez R, Carey W. Compliance with practice guidelines and risk of a first esophageal variceal hemorrhage in patients with cirrhosis. Clin Gastroenterol Hepatol 2010;8:703-8. [PMID: 20226879 DOI: 10.1016/j.cgh.2010.02.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
163 Lubel JS, Angus PW. Modern management of portal hypertension. Intern Med J. 2005;35:45-49. [PMID: 15667468 DOI: 10.1111/j.1445-5994.2004.00739.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
164 Villanueva C, Albillos A, Genescà J, Abraldes JG, Calleja JL, Aracil C, Bañares R, Morillas R, Poca M, Peñas B, Augustin S, Garcia-pagan JC, Pavel O, Bosch J. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension: Liver Failure/Cirrhosis/Portal Hypertension. Hepatology 2016;63:197-206. [DOI: 10.1002/hep.28264] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 12.6] [Reference Citation Analysis]
165 Laine L. Interventions for Primary Prevention of Esophageal Variceal Bleeding. Hepatology 2019;69:1382-4. [PMID: 30561058 DOI: 10.1002/hep.30463] [Reference Citation Analysis]
166 Lata J, Juránková J, Husová L, Senkyrík M, Díte P, Dastych M, Príbramská V, Kroupa R. Variceal bleeding in portal hypertension: bacterial infection and comparison of efficacy of intravenous and per-oral application of antibiotics--a randomized trial. Eur J Gastroenterol Hepatol. 2005;17:1105-1110. [PMID: 16148557 DOI: 10.1097/00042737-200510000-00015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
167 Bosch J, Abraldes JG, Albillos A, Aracil C, Bañares R, Berzigotti A, Calleja JL, de la Peña J, Escorsell A, García-pagán JC, Genescà J, Hernández-guerra M, Ripoll C, Planas R, Villanueva C. Hipertensión portal: recomendaciones para su evaluación y tratamiento. Gastroenterología y Hepatología 2012;35:421-50. [DOI: 10.1016/j.gastrohep.2012.02.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
168 Chen YP, Zhang Q, Dai L, Liang XE, Peng J, Hou JL. Is transient elastography valuable for high-risk esophageal varices prediction in patients with hepatitis-B-related cirrhosis? J Gastroenterol Hepatol. 2012;27:533-539. [PMID: 21871027 DOI: 10.1111/j.1440-1746.2011.06889.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
169 Manrai M, Dawra S, Kapoor R, Srivastava S, Singh A. Anemia in cirrhosis: An underestimated entity. World J Clin Cases 2022; 10(3): 777-789 [DOI: 10.12998/wjcc.v10.i3.777] [Reference Citation Analysis]
170 李会贤, 孔德润. 胃肾及脾肾分流道对胃底曲张静脉内镜治疗的影响. 世界华人消化杂志 2017; 25(20): 1805-1810 [DOI: 10.11569/wcjd.v25.i20.1805] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
171 Rockey DC. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 2008;134:8-14. [PMID: 18166342 DOI: 10.1053/j.gastro.2007.11.053] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 7.4] [Reference Citation Analysis]
172 Kheraj R, Tewani SK, Ketwaroo G, Leffler DA. Quality improvement in gastroenterology clinical practice. Clin Gastroenterol Hepatol. 2012;10:1305-1314. [PMID: 22902758 DOI: 10.1016/j.cgh.2012.08.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
173 Villanueva C, Planella M, Aracil C, López-Balaguer JM, González B, Miñana J, Balanzó J. Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose. Am J Gastroenterol 2005;100:624-30. [PMID: 15743361 DOI: 10.1111/j.1572-0241.2004.40665.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
174 Lim EJ, Gow PJ, Angus PW. Endoscopic variceal ligation for primary prophylaxis of esophageal variceal hemorrhage in pre-liver transplant patients: Variceal Banding in Liver Transplant Candidates. Liver Transpl 2009;15:1508-13. [DOI: 10.1002/lt.21857] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
175 Dell’Era A, Sotela JC, Fabris FM, Petazzi G, Reati R, Iannuzzi F, Nicolini A, Rumi MG, de Franchis R, Primignani M. Primary prophylaxis of variceal bleeding in cirrhotic patients: a cohort study. Dig Liver Dis. 2008;40:936-943. [PMID: 18468499 DOI: 10.1016/j.dld.2008.03.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
176 Tripathi D, Stanley AJ, Hayes PC, Patch D, Millson C, Mehrzad H, Austin A, Ferguson JW, Olliff SP, Hudson M, Christie JM;  Clinical Services and Standards Committee of the British Society of Gastroenterology. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015;64:1680-1704. [PMID: 25887380 DOI: 10.1136/gutjnl-2015-309262] [Cited by in Crossref: 260] [Cited by in F6Publishing: 197] [Article Influence: 37.1] [Reference Citation Analysis]
177 Pagliaro L. Lebrec D, Poynard T, Hillon P, Benhamou J-P. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. A controlled study [N Engl J Med 1981;305:1371-1374]. J Hepatol. 2002;36:148-150. [PMID: 11830324 DOI: 10.1016/s0168-8278(01)00307-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
178 de Franchis R. Endoscopy critics vs. endoscopy enthusiasts for primary prophylaxis of variceal bleeding. Hepatology. 2006;43:24-26. [PMID: 16374843 DOI: 10.1002/hep.21026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
179 Park WG, Shaheen NJ, Cohen J, Pike IM, Adler DG, Inadomi JM, Laine LA, Lieb JG 2nd, Rizk MK, Sawhney MS, Wani S. Quality indicators for EGD. Am J Gastroenterol 2015;110:60-71. [PMID: 25448872 DOI: 10.1038/ajg.2014.384] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
180 Liao WC, Hou MC, Chang CJ, Lee FY, Lin HC, Lee SD. Potential precipitating factors of esophageal variceal bleeding: a case-control study. Am J Gastroenterol. 2011;106:96-103. [PMID: 20823836 DOI: 10.1038/ajg.2010.342] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
181 Duah A, Nkrumah KN, Tachi K. Oesophageal varices in patients with liver cirrhosis attending a major tertiary hospital in Ghana. Pan Afr Med J 2018;31:230. [PMID: 31447987 DOI: 10.11604/pamj.2018.31.230.16657] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
182 Duah A, Nkrumah KN, Tachi K. Non-invasive markers as predictors of oesophageal varices in cirrhotic patient in a teaching hospital in Ghana. Ghana Med J 2019;53:142-9. [PMID: 31481810 DOI: 10.4314/gmj.v53i2.9] [Reference Citation Analysis]
183 Shukla R, Kramer J, Cao Y, Ying J, Tansel A, Walder A, Advani S, El-serag HB, Kanwal F. Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers. American Journal of Gastroenterology 2016;111:1778-87. [DOI: 10.1038/ajg.2016.440] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
184 Srirajaskanthan R, Preedy V. Diagnosis and management of alcoholic liver disease, a review. Clinical Effectiveness in Nursing 2006;9:e286-94. [DOI: 10.1016/j.cein.2006.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
185 Qureshi W, Adler DG, Davila R, Egan J, Hirota W, Leighton J, Rajan E, Zuckerman MJ, Fanelli R, Wheeler-Harbaugh J, Baron TH, Faigel DO;  Standards of Practice Committee. ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005. Gastrointest Endosc. 2005;62:651-655. [PMID: 16246673 DOI: 10.1016/j.gie.2005.07.031] [Cited by in Crossref: 88] [Cited by in F6Publishing: 72] [Article Influence: 5.5] [Reference Citation Analysis]
186 Colli A, Gana JC, Turner D, Yap J, Adams-Webber T, Ling SC, Casazza G. Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis. Cochrane Database Syst Rev. 2014;CD008760. [PMID: 25271409 DOI: 10.1002/14651858.cd008760.pub2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
187 Ripoll C, Zipprich A, Garcia-tsao G. Prognostic Factors in Compensated and Decompensated Cirrhosis. Curr Hepatology Rep 2014;13:171-9. [DOI: 10.1007/s11901-014-0234-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
188 Kim GH, Kim JH, Kim YJ, Ko SY, Choe WH, Kwon SY, Lee CH. Value of the APASL severity score in patients with acute variceal bleeding: a single center experience. Hepatol Int 2013;7:1058-64. [PMID: 26202035 DOI: 10.1007/s12072-013-9466-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
189 Luigiano C, Iabichino G, Judica A, Virgilio C, Peta V, Abenavoli L. Role of endoscopy in management of gastrointestinal complications of portal hypertension. World J Gastrointest Endosc 2015; 7(1): 1-12 [PMID: 25610530 DOI: 10.4253/wjge.v7.i1.1] [Cited by in CrossRef: 4] [Article Influence: 0.6] [Reference Citation Analysis]
190 de Franchis R, Dell’Era A. Non-invasive diagnosis of cirrhosis and the natural history of its complications. Best Pract Res Clin Gastroenterol. 2007;21:3-18. [PMID: 17223493 DOI: 10.1016/j.bpg.2006.07.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
191 Kim YD, Cheon GJ, Kim MY, Suk KT, Baik SK, Kim DJ. Changes in the clinical outcomes of variceal bleeding in cirrhotic patients: a 10-year experience in gangwon province, South Korea. Gut Liver 2012;6:476-81. [PMID: 23170153 DOI: 10.5009/gnl.2012.6.4.476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
192 Mukerji AN, Patel V, Jain A. Improving survival in decompensated cirrhosis. Int J Hepatol. 2012;2012:318627. [PMID: 22811919 DOI: 10.1155/2012/318627] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
193 Ilyas JA, Kanwal F. Primary prophylaxis of variceal bleeding. Gastroenterol Clin North Am 2014;43:783-94. [PMID: 25440925 DOI: 10.1016/j.gtc.2014.08.008] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
194 Lo GH, Chen WC, Wang HM, Lee CC. Controlled trial of ligation plus nadolol versus nadolol alone for the prevention of first variceal bleeding. Hepatology. 2010;52:230-237. [PMID: 20578138 DOI: 10.1002/hep.23617] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
195 Reiberger T, Püspök A, Schoder M, Baumann-Durchschein F, Bucsics T, Datz C, Dolak W, Ferlitsch A, Finkenstedt A, Graziadei I, Hametner S, Karnel F, Krones E, Maieron A, Mandorfer M, Peck-Radosavljevic M, Rainer F, Schwabl P, Stadlbauer V, Stauber R, Tilg H, Trauner M, Zoller H, Schöfl R, Fickert P. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wien Klin Wochenschr 2017;129:135-58. [PMID: 29063233 DOI: 10.1007/s00508-017-1262-3] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 12.4] [Reference Citation Analysis]
196 Reynaert H, Geerts A. Pharmacological rationale for the use of somatostatin and analogues in portal hypertension. Aliment Pharmacol Ther. 2003;18:375-386. [PMID: 12940922 DOI: 10.1046/j.1365-2036.2003.01657.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
197 Aguilar-olivos N, Motola-kuba M, Candia R, Arrese M, Méndez-sánchez N, Uribe M, Chávez-tapia NC. Hemodynamic effect of Carvedilol vs. propranolol in cirrhotic patients: Systematic review and meta-analysis. Annals of Hepatology 2014;13:420-8. [DOI: 10.1016/s1665-2681(19)30849-x] [Cited by in Crossref: 16] [Article Influence: 2.0] [Reference Citation Analysis]
198 Kumar A, Sharma P, Anikhindi SA, Prajapati R, Agarwal R, Sharma B, Bansal N, Singla V, Arora A. Can Non-Selective Beta-Blockers (NSBBs) Prevent Enlargement of Small Esophageal Varices in Patients with Cirrhosis? A Meta-analysis. J Clin Exp Hepatol. 2017;7:275-283. [PMID: 29234190 DOI: 10.1016/j.jceh.2017.09.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
199 Tayyem O, Bilal M, Samuel R, Merwat SK. Evaluation and management of variceal bleeding. Dis Mon 2018;64:312-20. [PMID: 29525376 DOI: 10.1016/j.disamonth.2018.02.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
200 Bosch J, Abraldes JG. Management of gastrointestinal bleeding in patients with cirrhosis of the liver. Semin Hematol. 2004;41:8-12. [PMID: 14872414 DOI: 10.1053/j.seminhematol.2003.11.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
201 Robertson M, Hayes P. Primary prophylaxis of variceal bleeding. Hepatol Int 2018;12:1-5. [PMID: 29396732 DOI: 10.1007/s12072-018-9846-1] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
202 Tiani C, Abraldes J, Bosch J. Portal hypertension: Pre-primary and primary prophylaxis of variceal bleeding. Digestive and Liver Disease 2008;40:318-27. [DOI: 10.1016/j.dld.2007.12.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
203 Perumalswami PV, Schiano TD. The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci 2011;56:1266-81. [PMID: 21416246 DOI: 10.1007/s10620-011-1619-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
204 Sharma P, Sarin SK. Improved survival with the patients with variceal bleed. Int J Hepatol. 2011;2011:356919. [PMID: 21994853 DOI: 10.4061/2011/356919] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
205 Garcia-tsao G, Sanyal AJ, Grace ND, Carey WD; the Practice Guidelines Committee of the American Association for the Study of Liver Diseases and the Practice Parameters Committee of the American College of Gastroenterology. Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis. Am J Gastroenterology 2007;102:2086-102. [DOI: 10.1111/j.1572-0241.2007.01481.x] [Cited by in Crossref: 219] [Cited by in F6Publishing: 165] [Article Influence: 14.6] [Reference Citation Analysis]
206 Vaughan RB, Chin-dusting JP. Current pharmacotherapy in the management of cirrhosis: focus on the hyperdynamic circulation. Expert Opinion on Pharmacotherapy 2005;4:625-37. [DOI: 10.1517/14656566.4.5.625] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
207 Donovan JP. ENDOSCOPIC MANAGEMENT OF THE LIVER TRANSPLANT PATIENT. Clinics in Liver Disease 2000;4:607-18. [DOI: 10.1016/s1089-3261(05)70129-x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
208 Hobolth L, Møller S, Grønbæk H, Roelsgaard K, Bendtsen F, Feldager Hansen E. Carvedilol or propranolol in portal hypertension? A randomized comparison. Scandinavian Journal of Gastroenterology 2012;47:467-74. [DOI: 10.3109/00365521.2012.666673] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
209 Mellinger JL, Volk ML. Multidisciplinary management of patients with cirrhosis: a need for care coordination. Clin Gastroenterol Hepatol. 2013;11:217-223. [PMID: 23142204 DOI: 10.1016/j.cgh.2012.10.040] [Cited by in Crossref: 67] [Cited by in F6Publishing: 52] [Article Influence: 6.7] [Reference Citation Analysis]
210 Vorobioff J, Groszmann R. Portal Hypertension—Molecular Mechanisms. Liver Pathophysiology. Elsevier; 2017. pp. 435-49. [DOI: 10.1016/b978-0-12-804274-8.00034-5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
211 Bosch J, García-pagán JC. Prevention of variceal rebleeding. The Lancet 2003;361:952-4. [DOI: 10.1016/s0140-6736(03)12778-x] [Cited by in Crossref: 272] [Cited by in F6Publishing: 77] [Article Influence: 14.3] [Reference Citation Analysis]
212 Chen WT, Lin CY, Sheen IS, Huang CW, Lin TN, Lin CJ, Jeng WJ, Huang CH, Ho YP, Chiu CT. MELD score can predict early mortality in patients with rebleeding after band ligation for variceal bleeding. World J Gastroenterol 2011; 17(16): 2120-2125 [PMID: 21547132 DOI: 10.3748/wjg.v17.i16.2120] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
213 Moon AM, Green PK, Rockey DC, Berry K, Ioannou GN. Hepatitis C eradication with direct-acting anti-virals reduces the risk of variceal bleeding. Aliment Pharmacol Ther 2020;51:364-73. [PMID: 31773763 DOI: 10.1111/apt.15586] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
214 Spiegel BM, Esrailian E, Eisen G. The budget impact of endoscopic screening for esophageal varices in cirrhosis. Gastrointest Endosc. 2007;66:679-692. [PMID: 17905009 DOI: 10.1016/j.gie.2007.02.048] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
215 Lipnik AJ, Pandhi MB, Khabbaz RC, Gaba RC. Endovascular Treatment for Variceal Hemorrhage: TIPS, BRTO, and Combined Approaches. Semin Intervent Radiol 2018;35:169-84. [PMID: 30087520 DOI: 10.1055/s-0038-1660795] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
216 García-pagán JC, Villanueva C, Vila MC, Albillos A, Genescà J, Ruiz-del-arbol L, planas R, Rodriguez M, Calleja JL, González A, Solà R, Balanzó J, Bosch J. Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive β-blockers. Gastroenterology 2001;121:908-14. [DOI: 10.1053/gast.2001.27993] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
217 Rondonotti E, Villa F, Dell’ Era A, Tontini GE, de Franchis R. Capsule endoscopy in portal hypertension. Clin Liver Dis. 2010;14:209-220. [PMID: 20682230 DOI: 10.1016/j.cld.2010.03.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
218 Ioannou GN, Doust J, Rockey DC. Terlipressin in acute oesophageal variceal haemorrhage: TERLIPRESSIN AND OESOPHAGEAL VARICEAL HAEMORRHAGE. Alimentary Pharmacology & Therapeutics 2003;17:53-64. [DOI: 10.1046/j.1365-2036.2003.01356.x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 81] [Article Influence: 5.8] [Reference Citation Analysis]
219 Villanueva C, Aracil C, Balanzó J. What to do with non-responders. In: Groszmann RJ, Bosch J, editors. Portal Hypertension in the 21st Century. Dordrecht: Springer Netherlands; 2004. pp. 337-48. [DOI: 10.1007/978-94-007-1042-9_34] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
220 Chassaignon C, Letoumelin P, Pateron D. Upper gastrointestinal haemorrhage in Emergency Departments in France: causes and management: . European Journal of Emergency Medicine 2003;10:290-5. [DOI: 10.1097/00063110-200312000-00010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
221 Peeraphatdit TB, Kamath PS, Shah VH. Beta-blockers in patients with advanced cirrhosis: Red light, green light, yellow light…. Liver Transpl 2017;23:725-6. [PMID: 28452116 DOI: 10.1002/lt.24780] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
222 Schepke M, Kleber G, Nürnberg D, Willert J, Koch L, Veltzke-Schlieker W, Hellerbrand C, Kuth J, Schanz S, Kahl S. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2004;40:65-72. [PMID: 15239087 DOI: 10.1002/hep.20284] [Cited by in Crossref: 148] [Cited by in F6Publishing: 111] [Article Influence: 8.2] [Reference Citation Analysis]
223 Samonakis DN, Triantos CK, Thalheimer U, Patch DW, Burroughs AK. Management of portal hypertension. Postgrad Med J. 2004;80:634-641. [PMID: 15537846 DOI: 10.1136/pgmj.2004.020446] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
224 Albillos A, Peñas B, Zamora J. Role of Endoscopy in Primary Prophylaxis for Esophageal Variceal Bleeding. Clinics in Liver Disease 2010;14:231-50. [DOI: 10.1016/j.cld.2010.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
225 Molleston JP, Shneider BL. Preventing variceal bleeding in infants and children: is less more? Gastroenterology 2013;145:719-22. [PMID: 23973849 DOI: 10.1053/j.gastro.2013.08.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
226 Wang XK, Wang P, Zhang Y, Qi SL, Chi K, Wang GC. A study on spleen transient elastography in predicting the degree of esophageal varices and bleeding. Medicine (Baltimore) 2019;98:e14615. [PMID: 30817578 DOI: 10.1097/MD.0000000000014615] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
227 Laine L, Abid S, Albillos A, Kamath PS, Vinel J, García-pagán JC. Treatment of Acute Bleeding. In: de Franchis R, editor. Portal Hypertension V. Oxford: Wiley-Blackwell; 2011. pp. 101-18. [DOI: 10.1002/9781444393989.ch10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
228 Kravetz D. Gastrointestinal bleeding: Secondary prophylaxis for variceal bleeding. Nat Rev Gastroenterol Hepatol 2010;7:10-1. [PMID: 20051968 DOI: 10.1038/nrgastro.2009.216] [Reference Citation Analysis]
229 Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Takesue M, Yoshida K, Kuboki M, Yamamoto S. Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization. Dig Dis Sci. 2006;51:352-358. [PMID: 16534680 DOI: 10.1007/s10620-006-3137-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
230 García-Pagán JC, Morillas R, Bañares R, Albillos A, Villanueva C, Vila C, Genescà J, Jimenez M, Rodriguez M, Calleja JL, Balanzó J, García-Durán F, Planas R, Bosch J; Spanish Variceal Bleeding Study Group. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT. Hepatology 2003;37:1260-6. [PMID: 12774003 DOI: 10.1053/jhep.2003.50211] [Cited by in Crossref: 121] [Cited by in F6Publishing: 84] [Article Influence: 6.4] [Reference Citation Analysis]
231 Talwalkar JA. Cost-Effectiveness of Treating Esophageal Varices. Clinics in Liver Disease 2006;10:679-89. [DOI: 10.1016/j.cld.2006.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
232 Gugig R, Rosenthal P. Management of portal hypertension in children. World J Gastroenterol 2012; 18(11): 1176-1184 [PMID: 22468080 DOI: 10.3748/wjg.v18.i11.1176] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
233 Mandorfer M, Reiberger T. Beta blockers and cirrhosis, 2016. Dig Liver Dis. 2017;49:3-10. [PMID: 27717792 DOI: 10.1016/j.dld.2016.09.013] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 7.7] [Reference Citation Analysis]
234 Møller S, Bendtsen F. Complications of cirrhosis. A 50 years flashback. Scand J Gastroenterol. 2015;50:763-780. [PMID: 25881709 DOI: 10.3109/00365521.2015.1021709] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
235 Klebl FH, Schölmerich J. Future expectations in the prophylaxis of intestinal bleeding. Best Pract Res Clin Gastroenterol 2008;22:373-87. [PMID: 18346690 DOI: 10.1016/j.bpg.2007.11.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
236 D'Amico G, De Franchis R;  Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003;38:599-612. [PMID: 12939586 DOI: 10.1053/jhep.2003.50385] [Cited by in Crossref: 530] [Cited by in F6Publishing: 440] [Article Influence: 27.9] [Reference Citation Analysis]
237 Kim H, Choi D, Lee JH, Lee SJ, Jo H, Gwak GY, Koh KC, Choi MS, Kim S. High-risk esophageal varices in patients treated with locoregional therapy for hepatocellular carcinoma: Assessment with liver computed tomography. World J Gastroenterol 2012; 18(35): 4905-4911 [PMID: 23002363 DOI: 10.3748/wjg.v18.i35.4905] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
238 Daves SM. The Liver and Vascular Surgery. Semin Cardiothorac Vasc Anesth 2000;4:275-88. [DOI: 10.1177/108925320000400409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
239 Vadera S, Yong CWK, Gluud LL, Morgan MY. Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices. Cochrane Database Syst Rev 2019;6:CD012673. [PMID: 31220333 DOI: 10.1002/14651858.CD012673.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
240 Mela M, Mancuso A, Burroughs A. Drug treatment for portal hypertension. Annals of Hepatology 2002;1:102-20. [DOI: 10.1016/s1665-2681(19)32169-6] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
241 Amitrano L, Guardascione MA, Bennato R, Manguso F, Balzano A. MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices. J Hepatol. 2005;42:820-825. [PMID: 15885352 DOI: 10.1016/j.jhep.2005.01.021] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 4.1] [Reference Citation Analysis]
242 Alqahtani SA, Jang S. Pathophysiology and Management of Variceal Bleeding. Drugs 2021;81:647-67. [PMID: 33710585 DOI: 10.1007/s40265-021-01493-2] [Reference Citation Analysis]
243 Fabes J, Ambler G, Shah B, Williams NR, Martin D, Davidson BR, Spiro M. Protocol for a prospective double-blind, randomised, placebo-controlled feasibility trial of octreotide infusion during liver transplantation. BMJ Open 2021;11:e055864. [PMID: 34857585 DOI: 10.1136/bmjopen-2021-055864] [Reference Citation Analysis]
244 Agasti AK, Mahajan AU, Phadke AY, Nathani PJ, Sawant P. Comparative randomized study on efficacy of losartan versus propranolol in lowering portal pressure in decompensated chronic liver disease. J Dig Dis. 2013;14:266-271. [PMID: 23280243 DOI: 10.1111/1751-2980.12025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
245 Ferguson JW, Tripathi D, Hayes PC. Endoscopic diagnosis, grading and predictors of bleeding in esophageal and gastric varices. Techniques in Gastrointestinal Endoscopy 2005;7:2-7. [DOI: 10.1016/j.tgie.2004.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
246 Rodrigues SG, Mendoza YP, Bosch J. Beta-blockers in cirrhosis: Evidence-based indications and limitations. JHEP Rep 2020;2:100063. [PMID: 32039404 DOI: 10.1016/j.jhepr.2019.12.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
247 Thabut D, Bureau C, Layese R, Bourcier V, Hammouche M, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Goria O, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle-Bladou C, Dao T, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Hillaire S, Di Martino V, Sutton A, Audureau E, Roudot-Thoraval F, Nahon P; ANRS CO12 CirVir group. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy. Gastroenterology 2019;156:997-1009.e5. [PMID: 30768988 DOI: 10.1053/j.gastro.2018.11.053] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 16.7] [Reference Citation Analysis]
248 Kim HY, So YH, Kim W, Ahn DW, Jung YJ, Woo H, Kim D, Kim MY, Baik SK. Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices. J Hepatol 2019;70:412-22. [PMID: 30389550 DOI: 10.1016/j.jhep.2018.10.018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
249 Döhler KD, Meyer M. Vasopressin analogues in the treatment of hepatorenal syndrome and gastrointestinal haemorrhage. Best Practice & Research Clinical Anaesthesiology 2008;22:335-50. [DOI: 10.1016/j.bpa.2008.02.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
250 Esmat S, Omarn D, Rashid L. Can we consider the right hepatic lobe size/albumin ratio a noninvasive predictor of oesophageal varices in hepatitis C virus-related liver cirrhotic Egyptian patients? Eur J Intern Med. 2012;23:267-272. [PMID: 22385886 DOI: 10.1016/j.ejim.2011.11.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
251 de Franchis R. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatol. 2008;49:520-527. [PMID: 18706733 DOI: 10.1016/j.jhep.2008.07.009] [Cited by in Crossref: 66] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
252 Ferro D, Celestini A, Violi F. Hyperfibrinolysis in liver disease. Clin Liver Dis 2009;13:21-31. [PMID: 19150306 DOI: 10.1016/j.cld.2008.09.008] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 4.0] [Reference Citation Analysis]
253 Cárdenas A, Baiges A, Hernandez-Gea V, Garcia-Pagan JC. Endoscopic hemostasis in acute esophageal variceal bleeding. Gastroenterol Clin North Am 2014;43:795-806. [PMID: 25440926 DOI: 10.1016/j.gtc.2014.08.009] [Cited by in Crossref: 7] [Article Influence: 0.9] [Reference Citation Analysis]
254 Hidaka H, Nakazawa T, Wang G, Kokubu S, Minamino T, Takada J, Tanaka Y, Okuwaki Y, Watanabe M, Tanabe S, Shibuya A, Koizumi W. Long-term administration of PPI reduces treatment failures after esophageal variceal band ligation: a randomized, controlled trial. J Gastroenterol 2012;47:118-26. [PMID: 21947706 DOI: 10.1007/s00535-011-0472-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
255 Kumar A, Jha SK, Mittal VV, Sharma P, Sharma BC, Sarin SK. Addition of Somatostatin After Successful Endoscopic Variceal Ligation Does not Prevent Early Rebleeding in Comparison to Placebo: A Double Blind Randomized Controlled Trial. J Clin Exp Hepatol 2015;5:204-12. [PMID: 26628838 DOI: 10.1016/j.jceh.2015.06.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
256 Raines DL, Dupont AW, Arguedas MR. Cost-effectiveness of hepatic venous pressure gradient measurements for prophylaxis of variceal re-bleeding. Aliment Pharmacol Ther 2004;19:571-81. [PMID: 14987326 DOI: 10.1111/j.1365-2036.2004.01875.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
257 Park WG, Shaheen NJ, Cohen J, Pike IM, Adler DG, Inadomi JM, Laine LA, Lieb JG 2nd, Rizk MK, Sawhney MS, Wani S. Quality indicators for EGD. Gastrointest Endosc 2015;81:17-30. [PMID: 25480101 DOI: 10.1016/j.gie.2014.07.057] [Cited by in Crossref: 55] [Cited by in F6Publishing: 38] [Article Influence: 6.9] [Reference Citation Analysis]
258 D'Amico G, Morabito A, D'Amico M, Pasta L, Malizia G, Rebora P, Valsecchi MG. Clinical states of cirrhosis and competing risks. J Hepatol. 2018;68:563-576. [PMID: 29111320 DOI: 10.1016/j.jhep.2017.10.020] [Cited by in Crossref: 116] [Cited by in F6Publishing: 97] [Article Influence: 23.2] [Reference Citation Analysis]
259 Garcia-Tsao G, Lim JK; Members of Veterans Affairs Hepatitis C Resource Center Program. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol. 2009;104:1802-1829. [PMID: 19455106 DOI: 10.1038/ajg.2009.191] [Cited by in Crossref: 168] [Cited by in F6Publishing: 146] [Article Influence: 12.9] [Reference Citation Analysis]
260 Seo YS. Prevention and management of gastroesophageal varices. Clin Mol Hepatol. 2018;24:20-42. [PMID: 29249128 DOI: 10.3350/cmh.2017.0064] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
261 Khan F, Tripathi D. Role of early transjugular intrahepatic portosystemic stent-shunt in acute variceal bleeding: An update of the evidence and future directions. World J Gastroenterol 2021; 27(44): 7612-7624 [PMID: 34908802 DOI: 10.3748/wjg.v27.i44.7612] [Reference Citation Analysis]
262 Lowe RC, Grace ND. Primary prophylaxis of variceal hemorrhage. Clin Liver Dis. 2001;5:665-676. [PMID: 11565136 DOI: 10.1016/s1089-3261(05)70187-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
263 Rittig N, Aagaard NK, Villadsen GE, Sandahl TD, Jessen N, Grønbaek H, George J. Randomised clinical study: acute effects of metformin versus placebo on portal pressure in patients with cirrhosis and portal hypertension. Aliment Pharmacol Ther 2021;54:320-8. [PMID: 34165199 DOI: 10.1111/apt.16460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
264 Opio CK, Garcia-tsao G. Managing Varices: Drugs, Bands, and Shunts. Gastroenterology Clinics of North America 2011;40:561-79. [DOI: 10.1016/j.gtc.2011.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
265 Moftah SG, Kamal S, Hanna AT. CT esophagography: Non invasive screening and grading of esophageal varices in cirrhosis. The Egyptian Journal of Radiology and Nuclear Medicine 2014;45:263-70. [DOI: 10.1016/j.ejrnm.2014.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
266 Zaman A. Portal hypertension-related bleeding: management of difficult cases. Clin Liver Dis 2006;10:353-70, ix. [PMID: 16971266 DOI: 10.1016/j.cld.2006.05.013] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
267 Barritt AS 4th, Arguedas MR. Practice patterns in screening for varices: an American survey. Dig Liver Dis. 2009;41:676-682. [PMID: 19251491 DOI: 10.1016/j.dld.2009.01.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
268 Laurain A, de Leusse A, Gincul R, Vanbiervliet G, Bramli S, Heyries L, Martane G, Amrani N, Serraj I, Saurin J, Borentain P, Filoche B, Duburque C, Gaudric M, Sogni P, Dumortier J. Oesophageal capsule endoscopy versus oesophago-gastroduodenoscopy for the diagnosis of recurrent varices: A prospective multicentre study. Digestive and Liver Disease 2014;46:535-40. [DOI: 10.1016/j.dld.2014.02.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
269 Nidegger D, Ragot S, Berthelémy P, Masliah C, Pilette C, Martin T, Bianchi A, Paupard T, Silvain C, Beauchant M. Cirrhosis and bleeding: the need for very early management. J Hepatol. 2003;39:509-514. [PMID: 12971959 DOI: 10.1016/s0168-8278(03)00322-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
270 Imperiale TF, Chalasani N, Klein RW. Measuring The Hemodynamic Response To Primary Pharmacoprophylaxis of Variceal Bleeding: A Cost-Effectiveness Analysis. American Journal of Gastroenterology 2003;98:2742-50. [DOI: 10.1111/j.1572-0241.2003.08729.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
271 Baik SK, Jeong PH, Ji SW, Yoo BS, Kim HS, Lee DK, Kwon SO, Kim YJ, Park JW, Chang SJ. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison. Am J Gastroenterol. 2005;100:631-635. [PMID: 15743362 DOI: 10.1111/j.1572-0241.2005.41381.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 4.5] [Reference Citation Analysis]
272 Sharma SK, Aggarwal R. Prediction of large esophageal varices in patients with cirrhosis of the liver using clinical, laboratory and imaging parameters. J Gastroenterol Hepatol. 2007;22:1909-1915. [PMID: 17914969 DOI: 10.1111/j.1440-1746.2006.04501.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
273 Li K, Neuberger J. The management of patients awaiting liver transplantation. Nat Rev Gastroenterol Hepatol 2009;6:648-59. [DOI: 10.1038/nrgastro.2009.163] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
274 Talwalkar JA, Kamath PS. An evidence-based medicine approach to beta-blocker therapy in patients with cirrhosis. Am J Med. 2004;116:759-766. [PMID: 15144913 DOI: 10.1016/j.amjmed.2004.03.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
275 Morales J, Moitinho E, Abraldes JG, Fernandez M, Bosch J. Effects of the V1a vasopressin agonist F-180 on portal hypertension-related bleeding in portal hypertensive rats. Hepatology;38:1378-83. [DOI: 10.1016/j.hep.2003.09.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
276 D’Amico G, Pietrosi G, Tarantino I, Pagliaro L. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology. 2003;124:1277-1291. [PMID: 12730868 DOI: 10.1016/s0016-5085(03)00269-5] [Cited by in Crossref: 141] [Cited by in F6Publishing: 25] [Article Influence: 7.4] [Reference Citation Analysis]
277 Al-Khafaji A, Huang DT. Critical care management of patients with end-stage liver disease. Crit Care Med 2011;39:1157-66. [PMID: 21336121 DOI: 10.1097/CCM.0b013e318211fdc4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
278 Funakoshi N, Ségalas-Largey F, Duny Y, Oberti F, Valats JC, Bismuth M, Daurès JP, Blanc P. Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: A meta-analysis. World J Gastroenterol 2010; 16(47): 5982-5992 [PMID: 21157975 DOI: 10.3748/wjg.v16.i47.5982] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
279 Brandenburger LA, Regenstein FG. Variceal Hemorrhage. Curr Treat Options Gastroenterol. 2002;5:73-80. [PMID: 11792240 DOI: 10.1007/s11938-002-0009-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
280 Bañares R, Albillos A, Rincón D, Alonso S, González M, Ruiz-del-arbol L, Salcedo M, Molinero L. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: A meta-analysis: Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: A meta-analysis. Hepatology 2002;35:609-15. [DOI: 10.1053/jhep.2002.31354] [Cited by in Crossref: 296] [Cited by in F6Publishing: 214] [Article Influence: 15.6] [Reference Citation Analysis]
281 Chen YI, Ghali P. Prevention and management of gastroesophageal varices in cirrhosis. Int J Hepatol. 2012;2012:750150. [PMID: 22577563 DOI: 10.1155/2012/750150] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
282 Longacre AV, Imaeda A, Garcia-Tsao G, Fraenkel L. A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage. Hepatology 2008;47:169-76. [PMID: 17935182 DOI: 10.1002/hep.21945] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
283 Al Mahtab M, M Noor E Alam S, A Rahim M, A Alam M, A Khondaker F, L Moben A, Mohsena M, Mohammad Fazle Akbar S. Hepatic Venous Pressure Gradient Measurement in Bangladeshi Cirrhotic Patients: A Correlation with Child's Status, Variceal Size, and Bleeding. Euroasian J Hepatogastroenterol. 2017;7:142-145. [PMID: 29201796 DOI: 10.5005/jp-journals-10018-1235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
284 Suk KT. Hepatic venous pressure gradient: clinical use in chronic liver disease. Clin Mol Hepatol. 2014;20:6-14. [PMID: 24757653 DOI: 10.3350/cmh.2014. 20.1.6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
285 Garcia-tsao G. Preventing the Development of Varices in Cirrhosis. Journal of Clinical Gastroenterology 2007;41:S300-4. [DOI: 10.1097/mcg.0b013e318157c63d] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
286 Augustin S, González A, Genescà J. Acute esophageal variceal bleeding: Current strategies and new perspectives. World J Hepatol 2010; 2(7): 261-274 [PMID: 21161008 DOI: 10.4254/wjh.v2.i7.261] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
287 Perri RE, Chiorean MV, Fidler JL, Fletcher JG, Talwalkar JA, Stadheim L, Shah ND, Kamath PS. A prospective evaluation of computerized tomographic (CT) scanning as a screening modality for esophageal varices. Hepatology. 2008;47:1587-1594. [PMID: 18393388 DOI: 10.1002/hep.22219] [Cited by in Crossref: 97] [Cited by in F6Publishing: 64] [Article Influence: 6.9] [Reference Citation Analysis]
288 Thabut D. [Gastrointestinal hemorrhage. How to prevent rebleeding: role of pharmacological and endoscopic treatments]. Gastroenterol Clin Biol 2004;28 Spec No 2:B73-82. [PMID: 15150499 DOI: 10.1016/s0399-8320(04)95242-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
289 Sharma P, Kumar A, Sharma BC, Sarin SK. Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices. Aliment Pharmacol Ther 2009;30:48-60. [PMID: 19392862 DOI: 10.1111/j.1365-2036.2009.04015.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
290 Gana JC, Cifuentes LI, Gattini D, Villarroel Del Pino LA, Peña A, Torres-Robles R. Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database Syst Rev 2019;9:CD010546. [PMID: 31550050 DOI: 10.1002/14651858.CD010546.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
291 Brunner F, Berzigotti A, Bosch J. Prevention and treatment of variceal haemorrhage in 2017. Liver Int. 2017;37 Suppl 1:104-115. [PMID: 28052623 DOI: 10.1111/liv.13277] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 7.4] [Reference Citation Analysis]
292 Simonetto DA, Shah VH, Kamath PS. Primary Prophylaxis of Variceal Bleeding. Clinics in Liver Disease 2014;18:335-45. [DOI: 10.1016/j.cld.2013.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
293 Garcia–tsao G. Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001;120:726-48. [DOI: 10.1053/gast.2001.22580] [Cited by in Crossref: 292] [Cited by in F6Publishing: 235] [Article Influence: 13.9] [Reference Citation Analysis]
294 Hernández-Gea V, Berbel C, Baiges A, García-Pagán JC. Acute variceal bleeding: risk stratification and management (including TIPS). Hepatol Int 2018;12:81-90. [PMID: 28634688 DOI: 10.1007/s12072-017-9804-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
295 D'amico G, Garcia-tsao G, Cales P, Escorsell A, Nevens F, Cestari R, Caletti G, Zoli M. Session 2 - Diagnosis of Portal Hypertension: How and When. In: de Franchis R, editor. Portal Hypertension III: Proceedings of the Third Baverno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford: Blackwell Science Ltd; 2001. pp. 36-64. [DOI: 10.1002/9780470760154.ch4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
296 Garcia-Pagan JC, De Gottardi A, Bosch J. Review article: the modern management of portal hypertension--primary and secondary prophylaxis of variceal bleeding in cirrhotic patients. Aliment Pharmacol Ther. 2008;28:178-186. [PMID: 18462268 DOI: 10.1111/j.1365-2036.2008.03729.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
297 Siddiqui MS, Stravitz RT. Intensive care unit management of patients with liver failure. Clin Liver Dis. 2014;18:957-978. [PMID: 25438294 DOI: 10.1016/j.cld.2014.07.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
298 Schreibman I, Meitz K, Kunselman AR, Downey M, Le T, Riley T. Defining the threshold: new data on the ability of capsule endoscopy to discriminate the size of esophageal varices. Dig Dis Sci 2011;56:220-6. [PMID: 20490679 DOI: 10.1007/s10620-010-1272-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
299 Suk KT, Baik SK, Yoon JH, Cheong JY, Paik YH, Lee CH, Kim YS, Lee JW, Kim DJ, Cho SW, Hwang SG, Sohn JH, Kim MY, Kim YB, Kim JG, Cho YK, Choi MS, Kim HJ, Lee HW, Kim SU, Kim JK, Choi JY, Jun DW, Tak WY, Lee BS, Jang BK, Chung WJ, Kim HS, Jang JY, Jeong SW, Kim SG, Kwon OS, Jung YK, Choe WH, Lee JS, Kim IH, Shim JJ, Cheon GJ, Bae SH, Seo YS, Choi DH, Jang SJ; Korean Association for the Study of the Liver. Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol. 2012;18:1-21. [PMID: 22511898 DOI: 10.3350/kjhep.2012.18.1.1] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 9.4] [Reference Citation Analysis]
300 Turnes J, Hernández-Guerra M, Abraldes JG, Bellot P, Oliva R, García-Pagán JC, Bosch J. Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis. Hepatology. 2006;43:34-41. [PMID: 16374847 DOI: 10.1002/hep.21000] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
301 Krag A, Simonsen L, Henriksen JH, Ottesen L, Bendtsen F. Effect of meal and propranolol on whole body and splanchnic oxygen consumption in patients with cirrhosis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2006;291:G8-G15. [DOI: 10.1152/ajpgi.00315.2005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
302 Biecker E. Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension. ISRN Hepatol. 2013;2013:541836. [PMID: 27335828 DOI: 10.1155/2013/541836] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
303 Merkel C, Marin R, Angeli P, Zanella P, Felder M, Bernardinello E, Cavallarin G, Bolognesi M, Donada C, Bellini B, Torboli P, Gatta A;  Gruppo Triveneto per l'Ipertensione Portale. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology. 2004;127:476-484. [PMID: 15300580 DOI: 10.1053/j.gastro.2004.05.004] [Cited by in Crossref: 187] [Cited by in F6Publishing: 135] [Article Influence: 10.4] [Reference Citation Analysis]
304 Koshy AN, Farouque O, Cailes B, Ko J, Han HC, Weinberg L, Testro A, Robertson M, Teh AW, Lim HS, Gow PJ. Prediction of Perioperative Cardiovascular Events in Liver Transplantation. Transplantation 2021;105:593-601. [PMID: 32413014 DOI: 10.1097/TP.0000000000003306] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
305 de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis. 2001;5:645-663. [PMID: 11565135 DOI: 10.1016/s1089-3261(05)70186-0] [Cited by in Crossref: 233] [Cited by in F6Publishing: 70] [Article Influence: 11.7] [Reference Citation Analysis]
306 Narváez-Rivera RM, Cortez-Hernández CA, González-González JA, Tamayo-de la Cuesta JL, Zamarripa-Dorsey F, Torre-Delgadillo A, Rivera-Ramos JF, Vinageras-Barroso JI, Muneta-Kishigami JE, Blancas-Valencia JM, Antonio-Manrique M, Valdovinos-Andraca F, Brito-Lugo P, Hernández-Guerrero A, Bernal-Reyes R, Sobrino-Cossío S, Aceves-Tavares GR, Huerta-Guerrero HM, Moreno-Gómez N, Bosques-Padilla FJ. [Mexican consensus on portal hypertension]. Rev Gastroenterol Mex 2013;78:92-113. [PMID: 23664429 DOI: 10.1016/j.rgmx.2013.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
307 Rye K, Scott R, Mortimore G, Lawson A, Austin A, Freeman J. Towards noninvasive detection of oesophageal varices. Int J Hepatol 2012;2012:343591. [PMID: 22506126 DOI: 10.1155/2012/343591] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
308 Hemstreet BA. Evaluation of Carvedilol for the Treatment of Portal Hypertension. Pharmacotherapy 2004;24:94-104. [DOI: 10.1592/phco.24.1.94.34805] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
309 Bendtsen F, Krag A, Møller S. Treatment of acute variceal bleeding. Dig Liver Dis 2008;40:328-36. [PMID: 18243077 DOI: 10.1016/j.dld.2007.12.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
310 Turnes J, Garcia-Pagan JC, Abraldes JG, Hernandez-Guerra M, Dell'Era A, Bosch J. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterol. 2006;101:506-512. [PMID: 16542287 DOI: 10.1111/j.1572-0241.2006.00453.x] [Cited by in Crossref: 154] [Cited by in F6Publishing: 129] [Article Influence: 9.6] [Reference Citation Analysis]
311 Hernández FT, Zapater P, De-Madaria E, Palazón JM, Pascual S, Irurzun J, Such J, Perez-Mateo M, Horga JF. Functional status of beta-2-adrenoceptor in isolated membranes of mature erythrocytes from patients with cirrhosis and oesophageal varices. Vascul Pharmacol 2006;44:464-8. [PMID: 16624626 DOI: 10.1016/j.vph.2006.03.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
312 Bozic MA, Puri K, Molleston JP. Screening and Prophylaxis for Varices in Children with Liver Disease. Curr Gastroenterol Rep 2015;17. [DOI: 10.1007/s11894-015-0450-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
313 Haq I, Tripathi D. Recent advances in the management of variceal bleeding. Gastroenterol Rep (Oxf)5:113-126. [PMID: 28533909 DOI: 10.1093/gastro/gox007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 5.6] [Reference Citation Analysis]
314 Gulamhusein AF, Kamath PS. The epidemiology and pathogenesis of gastrointestinal varices. Techniques in Gastrointestinal Endoscopy 2017;19:62-8. [DOI: 10.1016/j.tgie.2017.03.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
315 Maruyama H, Kobayashi K, Kiyono S, Ogasawara S, Ooka Y, Suzuki E, Chiba T, Kato N, Komiyama Y, Takawa M, Nagamatsu H, Shiina S. Incidence and hemodynamic feature of risky esophageal varices with lower hepatic venous pressure gradient. Int J Med Sci 2019;16:1614-20. [PMID: 31839749 DOI: 10.7150/ijms.37040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
316 D’amico G, Perricone G. Prediction of Decompensation in Patients with Compensated Cirrhosis: Does Etiology Matter? Curr Hepatology Rep 2019;18:144-56. [DOI: 10.1007/s11901-019-00473-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
317 Zhang J, Tao R, You Z, Dai Y, Fan Y, Cui J, Mao Q, Wang J. Gamna-Gandy bodies of the spleen detected with susceptibility weighted imaging: maybe a new potential non-invasive marker of esophageal varices. PLoS One 2013;8:e55626. [PMID: 23383250 DOI: 10.1371/journal.pone.0055626] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
318 Talwalkar JA, Kamath PS. Influence of Recent Advances in Medical Management on Clinical Outcomes of Cirrhosis. Mayo Clinic Proceedings 2005;80:1501-8. [DOI: 10.4065/80.11.1501] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
319 Rajvanshi P, Kowdley KV. Prediction of varices in patients with cirrhosis: a high-stakes numbers game? J Clin Gastroenterol 2002;34:4-5. [PMID: 11743239 DOI: 10.1097/00004836-200201000-00003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
320 Mosli MH, Aljudaibi B, Almadi M, Marotta P. The safety and efficacy of gastric fundal variceal obliteration using N-butyl-2-cyanoacrylate; the experience of a single canadian tertiary care centre. Saudi J Gastroenterol. 2013;19:152-159. [PMID: 23828744 DOI: 10.4103/1319-3767.114508] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
321 Garcia-tsao G. Portal hypertension: . Current Opinion in Gastroenterology 2003;19:250-8. [DOI: 10.1097/00001574-200305000-00008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
322 Wadhawan M, Dubey S, Sharma BC, Sarin SK, Sarin SK. Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child’s status. Dig Dis Sci. 2006;51:2264-2269. [PMID: 17080245 DOI: 10.1007/s10620-006-9310-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 3.2] [Reference Citation Analysis]
323 López-Méndez E, Uribe M. Beta blockers in portal hypertension. Are they really a good option? Ann Hepatol 2006;5:86-91. [PMID: 16807514 [PMID: 16807514 DOI: 10.1016/s1665-2681(19)32023-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
324 Proctor DD. Critical issues in digestive diseases. Clin Chest Med 2003;24:623-32. [PMID: 14710694 DOI: 10.1016/s0272-5231(03)00103-5] [Reference Citation Analysis]
325 Kodama H, Aikata H, Takaki S, Takahashi S, Toyota N, Ito K, Chayama K. Evaluation of patients with esophageal varices after endoscopic injection sclerotherapy using multiplanar reconstruction MDCT images. AJR Am J Roentgenol. 2009;192:122-130. [PMID: 19098190 DOI: 10.2214/ajr.08.1268] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
326 Peck-Radosavljevic M, Angermayr B, Datz C, Ferlitsch A, Ferlitsch M, Fuhrmann V, Häfner M, Kramer L, Maieron A, Payer B. Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wien Klin Wochenschr. 2013;125:200-219. [PMID: 23579878 DOI: 10.1007/s00508-013-0337-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
327 Kim SJ, Choi CW, Kang DH, Kim HW, Park SB, Hong YM, Yoon KT, Cho M, Nam HS, Islam SB. Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active bleeding or stigmata increases the risk of rebleeding. Clin Mol Hepatol 2016;22:466-76. [PMID: 28081590 DOI: 10.3350/cmh.2016.0063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
328 Sarin SK, Kumar A, Angus PW, Baijal SS, Baik SK, Bayraktar Y, Chawla YK, Choudhuri G, Chung JW, de Franchis R, de Silva HJ, Garg H, Garg PK, Helmy A, Hou MC, Jafri W, Jia JD, Lau GK, Li CZ, Lui HF, Maruyama H, Pandey CM, Puri AS, Rerknimitr R, Sahni P, Saraya A, Sharma BC, Sharma P, Shiha G, Sollano JD, Wu J, Xu RY, Yachha SK, Zhang C; Asian Pacific Association for the Study of the Liver (APASL) Working Party on Portal Hypertension. Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations. Hepatol Int. 2011;5:607-624. [PMID: 21484145 DOI: 10.1007/s12072-010-9236-9] [Cited by in Crossref: 67] [Cited by in F6Publishing: 49] [Article Influence: 6.1] [Reference Citation Analysis]
329 Cárdenas A. Management of acute variceal bleeding: emphasis on endoscopic therapy. Clin Liver Dis. 2010;14:251-262. [PMID: 20682233 DOI: 10.1016/j.cld.2010.03.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
330 Pérez-ayuso RM, Valderrama S, Espinoza M, Rollán A, Sánchez R, Otarola F, Medina B, Riquelme A. Endoscopic band ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhotic patients with high risk esophageal varices. Annals of Hepatology 2010;9:15-22. [DOI: 10.1016/s1665-2681(19)31674-6] [Cited by in Crossref: 11] [Article Influence: 0.9] [Reference Citation Analysis]
331 D’Amico G, Morabito A. Noninvasive markers of esophageal varices: another round, not the last. Hepatology. 2004;39:30-34. [PMID: 14752818 DOI: 10.1002/hep.20018] [Cited by in Crossref: 57] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
332 Kim SE, Jung DM, Park JW, Ju Y, Lee B, Kim HS, Suk KT, Jang MK, Park SH, Kang JG, Soh JS, Lim H, Kang HS, Moon SH, Kim C, Lee S, Kim JH, Lee MS, Kim DJ, Ihm SH, Park C. Baseline Renal Function Predicts Hyponatremia in Liver Cirrhosis Patients Treated with Terlipressin for Variceal Bleeding. Gastroenterol Res Pract 2017;2017:7610374. [PMID: 29075291 DOI: 10.1155/2017/7610374] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
333 Barbu LA, Mărgăritescu ND, Şurlin MV. Diagnosis and Treatment Algorithms of Acute Variceal Bleeding. Curr Health Sci J 2017;43:191-200. [PMID: 30595875 DOI: 10.12865/CHSJ.43.03.02] [Reference Citation Analysis]
334 Baig WW, Nagaraja MV, Varma M, Prabhu R. Platelet count to spleen diameter ratio for the diagnosis of esophageal varices: Is it feasible? Can J Gastroenterol 2008;22:825-8. [PMID: 18925306 DOI: 10.1155/2008/287274] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
335 Ishiguro H, Saito S, Imazu H, Aihara H, Kato T, Tajiri H. Esophageal Capsule Endoscopy for Screening Esophageal Varices among Japanese Patients with Liver Cirrhosis. Gastroenterol Res Pract. 2012;2012:946169. [PMID: 22190914 DOI: 10.1155/2012/946169] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
336 Wells M, Chande N, Adams P, Beaton M, Levstik M, Boyce E, Mrkobrada M. Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther 2012;35:1267-78. [DOI: 10.1111/j.1365-2036.2012.05088.x] [Cited by in Crossref: 128] [Cited by in F6Publishing: 84] [Article Influence: 12.8] [Reference Citation Analysis]
337 Patel P, Rotundo L, Orosz E, Afridi F, Pyrsopoulos N. Hospital teaching status on the outcomes of patients with esophageal variceal bleeding in the United States. World J Hepatol 2020; 12(6): 288-297 [PMID: 32742571 DOI: 10.4254/wjh.v12.i6.288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
338 Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, Pandya P, Sitaraman S, Shen J. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol. 2003;98:653-659. [PMID: 12650802 DOI: 10.1111/j.1572-0241.2003.07294.x] [Cited by in Crossref: 264] [Cited by in F6Publishing: 221] [Article Influence: 13.9] [Reference Citation Analysis]
339 Villanueva C, Aracil C, López-Balaguer JM, Balanzó J. [Combined treatments for esophageal varices]. Gastroenterol Hepatol 2003;26:514-23. [PMID: 14534024 DOI: 10.1016/s0210-5705(03)70403-8] [Reference Citation Analysis]
340 Zipprich A, Winkler M, Seufferlein T, Dollinger MM. Comparison of balloon vs. straight catheter for the measurement of portal hypertension. Aliment Pharmacol Ther. 2010;32:1351-1356. [PMID: 21050237 DOI: 10.1111/j.1365-2036.2010.04484.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
341 Abraldes JG, Bosch J. Somatostatin and analogues in portal hypertension. Hepatology 2002;35:1305-12. [PMID: 12029614 DOI: 10.1053/jhep.2002.33469] [Cited by in Crossref: 72] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
342 Bosch J. A la carte or menu fixe: Improving pharmacologic therapy of portal hypertension: A La Carte or Menu Fixe: Improving Pharmacologic Therapy of Portal Hypertension. Hepatology 2002;36:1330-2. [DOI: 10.1002/hep.1840360606] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
343 Jwa HY, Cho YK, Choi EK, Kim HU, Song HJ, Na SY, Boo SJ, Jeong SU, Kim BS, Lee BW, Song BC. Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis. Clin Mol Hepatol 2016;22:183-7. [PMID: 27044771 DOI: 10.3350/cmh.2016.22.1.183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
344 Horne PM. Portal hypertension and risk of esophageal bleeding. Nurse Pract 2016;41:1-3. [PMID: 27434385 DOI: 10.1097/01.NPR.0000480594.39784.54] [Reference Citation Analysis]
345 González-abraldes J, Albillos A, Bañares R, Del Arbol LR, Moitinho E, Rodríguez C, González M, Escorsell A, García-pagán JC, Bosch J. Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology 2001;121:382-8. [DOI: 10.1053/gast.2001.26288] [Cited by in Crossref: 118] [Cited by in F6Publishing: 98] [Article Influence: 5.6] [Reference Citation Analysis]
346 Wang J, Tian XG, Li Y, Zhang CQ, Liu FL, Cui Y, Liu JY. Comparison of modified percutaneous transhepatic variceal embolization and endoscopic cyanoacrylate injection for gastric variceal rebleeding. World J Gastroenterol 2013; 19(5): 706-714 [PMID: 23430149 DOI: 10.3748/wjg.v19.i5.706] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
347 Kim H, Choi D, Gwak GY, Lee JH, Park MK, Lee HIe, Kim SH, Nam S, Yoo EY, Do YS. Evaluation of esophageal varices on liver computed tomography: receiver operating characteristic analyses of the performance of radiologists and endoscopists. J Gastroenterol Hepatol. 2009;24:1534-1540. [PMID: 19486446 DOI: 10.1111/j.1440-1746.2009.05849.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
348 Goshima S, Kanematsu M, Kondo H, Tsuge Y, Watanabe H, Shiratori Y, Onozuka M, Moriyama N. Detection and grading for esophageal varices in patients with chronic liver damage: comparison of gadolinium-enhanced and unenhanced steady-state coherent MR images. Magn Reson Imaging 2009;27:1230-5. [PMID: 19559558 DOI: 10.1016/j.mri.2009.05.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
349 Reiberger T, Bucsics T, Paternostro R, Pfisterer N, Riedl F, Mandorfer M. Small Esophageal Varices in Patients with Cirrhosis-Should We Treat Them? Curr Hepatol Rep. 2018;17:301-315. [PMID: 30546995 DOI: 10.1007/s11901-018-0420-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
350 Qi XS, Bao YX, Bai M, Xu WD, Dai JN, Guo XZ. Nonselective beta-blockers in cirrhotic patients with no or small varices: A meta-analysis. World J Gastroenterol 2015; 21(10): 3100-3108 [PMID: 25780311 DOI: 10.3748/wjg.v21.i10.3100] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
351 Lebrec D. Prevention of first variceal bleeding: drugs. In: Groszmann RJ, Bosch J, editors. Portal Hypertension in the 21st Century. Dordrecht: Springer Netherlands; 2004. pp. 221-6. [DOI: 10.1007/978-94-007-1042-9_23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
352 Zacharias AP, Jeyaraj R, Hobolth L, Bendtsen F, Gluud LL, Morgan MY. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices. Cochrane Database Syst Rev. 2018;10:CD011510. [PMID: 30372514 DOI: 10.1002/14651858.cd011510.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
353 Cremers I, Ribeiro S. Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis. Therap Adv Gastroenterol. 2014;7:206-216. [PMID: 25177367 DOI: 10.1177/1756283x14538688] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
354 de Faria AA, Dias CAF, Dias Moetzsohn L, de Castro Carvalho S, Ferrari TA, Nunes Arantes V. Feasibility of transnasal endoscopy in screening for esophageal and gastric varices in patients with chronic liver disease. Endosc Int Open 2017;5:E646-51. [PMID: 28691048 DOI: 10.1055/s-0043-107781] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
355 Garcia-tsao G. Cirrhosis and Its Sequelae. Goldman's Cecil Medicine. Elsevier; 2012. pp. 999-1007. [DOI: 10.1016/b978-1-4377-1604-7.00156-1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
356 Yang LB, Xu JY, Tantai XX, Li H, Xiao CL, Yang CF, Zhang H, Dong L, Zhao G. Non-invasive prediction model for high-risk esophageal varices in the Chinese population. World J Gastroenterol 2020; 26(21): 2839-2851 [PMID: 32550759 DOI: 10.3748/wjg.v26.i21.2839] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
357 Suk KT. Hepatic venous pressure gradient: clinical use in chronic liver disease. Clin Mol Hepatol. 2014;20:6-14. [PMID: 24757653 DOI: 10.3350/cmh.2014. 20.1.6] [Reference Citation Analysis]
358 Thalheimer U, Bosch J, Burroughs AK. How to prevent varices from bleeding: shades of grey--the case for nonselective beta blockers. Gastroenterology. 2007;133:2029-2036. [PMID: 18054573 DOI: 10.1053/j.gastro.2007.10.028] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
359 Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology. 2008;134:1715-1728. [PMID: 18471549 DOI: 10.1053/j.gastro.2008.03.007] [Cited by in Crossref: 215] [Cited by in F6Publishing: 174] [Article Influence: 15.4] [Reference Citation Analysis]
360 Ginès P, Fernández J, Durand F, Saliba F. Management of critically-ill cirrhotic patients. J Hepatol. 2012;56 Suppl 1:S13-S24. [PMID: 22300462 DOI: 10.1016/s0168-8278(12)60003-8] [Cited by in Crossref: 86] [Cited by in F6Publishing: 27] [Article Influence: 8.6] [Reference Citation Analysis]
361 Suk KT. Hepatic venous pressure gradient: clinical use in chronic liver disease. Clin Mol Hepatol. 2014;20:6-14. [PMID: 24757653 DOI: 10.3350/cmh.2014.20.1.6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
362 Henriksen JH, Bendtsen F, Hansen EF, Møller S. Acute non-selective β-adrenergic blockade reduces prolonged frequency-adjusted Q–T interval (QTc) in patients with cirrhosis. Journal of Hepatology 2004;40:239-46. [DOI: 10.1016/j.jhep.2003.10.026] [Cited by in Crossref: 85] [Cited by in F6Publishing: 61] [Article Influence: 4.7] [Reference Citation Analysis]
363 Heo JY, Kim BK, Park JY, Kim DY, Ahn SH, Tak WY, Kweon YO, Han KH, Park SY, Kim SU. Multicenter Retrospective Risk Assessment of Esophageal Variceal Bleeding in Patients with Cirrhosis: An Acoustic Radiation Force Impulse Elastography-Based Prediction Model. Gut Liver 2019;13:206-14. [PMID: 30602219 DOI: 10.5009/gnl18292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
364 Patidar KR, Sydnor M, Sanyal AJ. Transjugular intrahepatic portosystemic shunt. Clin Liver Dis 2014;18:853-76. [PMID: 25438287 DOI: 10.1016/j.cld.2014.07.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
365 Vorobioff JD, Groszmann RJ. Hepatic venous pressure gradient measurement in pre-primary and primary prophylaxis of variceal hemorrhage. Annals of Hepatology 2013;12:22-9. [DOI: 10.1016/s1665-2681(19)31381-x] [Cited by in Crossref: 12] [Article Influence: 1.3] [Reference Citation Analysis]
366 Maruyama H, Yokosuka O. Pathophysiology of portal hypertension and esophageal varices. Int J Hepatol. 2012;2012:895787. [PMID: 22666604 DOI: 10.1155/2012/895787] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
367 Klebl F, Bregenzer N, Schöfer L, Tamme W, Langgartner J, Schölmerich J, Messmann H. Risk factors for mortality in severe upper gastrointestinal bleeding. Int J Colorectal Dis 2005;20:49-56. [PMID: 15322836 DOI: 10.1007/s00384-004-0624-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
368 Minor MA, Grace ND. Pharmacologic therapy of portal hypertension. Clin Liver Dis. 2006;10:563-581. [PMID: 17162228 DOI: 10.1016/j.cld.2006.08.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
369 Zanetto A, Garcia-Tsao G. Management of acute variceal hemorrhage. F1000Res 2019;8:F1000 Faculty Rev-966. [PMID: 31281637 DOI: 10.12688/f1000research.18807.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
370 Escorsell A, Bandi JC, Andreu V, Moitinho E, García-Pagán JC, Bosch J, Rodés J. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology. 2001;120:161-169. [PMID: 11208725 DOI: 10.1053/gast.2001.20892] [Cited by in Crossref: 132] [Cited by in F6Publishing: 110] [Article Influence: 6.3] [Reference Citation Analysis]
371 Garbuzenko DV, Arefyev NO. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: An update and review of the literature. J Evid Based Med 2020;13:313-24. [PMID: 33037792 DOI: 10.1111/jebm.12407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
372 Vorobioff JD, Ferretti SE, Zangroniz P, Gamen M, Picabea E, Bessone FO, Reggiardo V, Diez AR, Tanno M, Cuesta C. Octreotide enhances portal pressure reduction induced by propranolol in cirrhosis: a randomized, controlled trial. Am J Gastroenterol. 2007;102:2206-2213. [PMID: 17608776 DOI: 10.1111/j.1572-0241.2007.01390.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
373 Biecker E, Classen L, Sauerbruch T, Schepke M. Does therapy of oesophageal varices influences the progression of varices? Eur J Gastroenterol Hepatol 2009;21:751-5. [PMID: 19369883 DOI: 10.1097/MEG.0b013e32830fe491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
374 Huang Y, Lin H, Chang Y, Yang Y, Lee S, Hong C, Hong C. Hemodynamic Effects of Synephrine Treatment in Portal Hypertensive Rats. Japanese Journal of Pharmacology 2001;85:183-8. [DOI: 10.1254/jjp.85.183] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
375 Garcia-Tsao G. Portal hypertension. Curr Opin Gastroenterol. 2002;18:351-359. [PMID: 17033306 DOI: 10.1097/00001574-200205000-00009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
376 Kim SH, Kim YJ, Lee JM, Choi KD, Chung YJ, Han JK, Lee JY, Lee MW, Han CJ, Choi JI, Shin KS, Choi BI. Esophageal varices in patients with cirrhosis: multidetector CT esophagography--comparison with endoscopy. Radiology. 2007;242:759-768. [PMID: 17229872 DOI: 10.1148/radiol.2423050784] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
377 Qi X, Guo X, Li H, Liu X, Deng H. Knowledge about non-invasive diagnostic tests for varices in liver cirrhosis: A questionnaire survey to the Gastroenterology Branch of the Liaoning Medical Association, China. Gastroenterol Rep (Oxf) 2016;4:141-7. [PMID: 26159631 DOI: 10.1093/gastro/gov031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
378 Suvak B, Kekilli M, Beyazıt Y, Okten S, Tanoglu A, Sasmaz N. Is computerised tomography better than fibreoptic gastroscopy for early detection of gastric varices? Prz Gastroenterol 2017;12:34-7. [PMID: 28337234 DOI: 10.5114/pg.2016.63284] [Reference Citation Analysis]
379 de Franchis R, Eisen GM, Laine L, Fernandez-Urien I, Herrerias JM, Brown RD, Fisher L, Vargas HE, Vargo J, Thompson J. Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. Hepatology. 2008;47:1595-1603. [PMID: 18435461 DOI: 10.1002/hep.22227] [Cited by in Crossref: 113] [Cited by in F6Publishing: 86] [Article Influence: 8.1] [Reference Citation Analysis]
380 Mahmoud HS, Mostafa EF, Mohammed MA. Role of portal haemodynamic parameters in prediction of oesophageal varices in cirrhotic patients. Arab J Gastroenterol 2014;15:130-4. [PMID: 25499211 DOI: 10.1016/j.ajg.2014.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
381 Sass DA, Chopra KB. Portal hypertension and variceal hemorrhage. Med Clin North Am. 2009;93:837-853, vii-viii. [PMID: 19577117 DOI: 10.1016/j.mcna.2009.03.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
382 Albillos A. Preventing First Variceal Hemorrhage in Cirrhosis. Journal of Clinical Gastroenterology 2007;41:S305-11. [DOI: 10.1097/mcg.0b013e318150d3c6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
383 Karadsheh Z, Allison H. Primary prevention of variceal bleeding: pharmacological therapy versus endoscopic banding. N Am J Med Sci. 2013;5:573-579. [PMID: 24350068 DOI: 10.4103/1947-2714.120791] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
384 Garcia-Tsao G. Portal hypertension. Curr Opin Gastroenterol. 2006;22:254-262. [PMID: 16550040 DOI: 10.1097/01.mog.0000218962.93806.9a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
385 Baiges A, Hernández-Gea V, Bosch J. Pharmacologic prevention of variceal bleeding and rebleeding. Hepatol Int 2018;12:68-80. [PMID: 29210030 DOI: 10.1007/s12072-017-9833-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
386 Ríos E, Serón P, Lanas F, Bonfill X, Quigley EM, Alonso-Coello P. Evaluation of the quality of clinical practice guidelines for the management of esophageal or gastric variceal bleeding. Eur J Gastroenterol Hepatol. 2014;26:422-431. [PMID: 24535595 DOI: 10.1097/MEG.0000000000000033] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
387 Colli A, Gana JC, Yap J, Adams-Webber T, Rashkovan N, Ling SC, Casazza G. Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis. Cochrane Database Syst Rev. 2017;4:CD008759. [PMID: 28444987 DOI: 10.1002/14651858.cd008759.pub2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
388 Jothimani D, Danielraj S, Nallathambi B, Pandurangan B, Kalyanasundaram S, Subbiah K, Ramachandran H, Venugopal R, Dhas D, Rela M. Optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic. Clin Radiol 2021;76:550.e1-7. [PMID: 33820640 DOI: 10.1016/j.crad.2021.02.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
389 Sarin SK, Kumar A. Endoscopic treatment of gastric varices. Clin Liver Dis. 2014;18:809-827. [PMID: 25438285 DOI: 10.1016/j.cld.2014.07.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
390 Vater Y, Dembo G, Levy A, Hunter C, Martay K. Adjunct drugs in liver transplantation. Seminars in Anesthesia, Perioperative Medicine and Pain 2002;21:285-97. [DOI: 10.1053/sane.2002.34196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
391 Garcia-tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding-Unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference. Hepatology 2008;47:1764-72. [DOI: 10.1002/hep.22273] [Cited by in Crossref: 180] [Cited by in F6Publishing: 138] [Article Influence: 12.9] [Reference Citation Analysis]
392 Italian Association for the Study of the Liver (AISF). Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis 2021;53:1089-104. [PMID: 34321192 DOI: 10.1016/j.dld.2021.06.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
393 Garcı́a-pagán JC, Bosch J. Medical treatment of portal hypertension. Best Practice & Research Clinical Gastroenterology 2000;14:895-909. [DOI: 10.1053/bega.2000.0137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
394 Arora G, Keeffe EB. Management of Chronic Liver Failure Until Liver Transplantation. Medical Clinics of North America 2008;92:839-60. [DOI: 10.1016/j.mcna.2008.03.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
395 Villanueva C, Graupera I, Aracil C, Alvarado E, Miñana J, Puente Á, Hernandez-Gea V, Ardevol A, Pavel O, Colomo A, Concepción M, Poca M, Torras X, Reñe JM, Guarner C. A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis. Hepatology 2017;65:1693-707. [PMID: 28100019 DOI: 10.1002/hep.29056] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 8.4] [Reference Citation Analysis]
396 Shi M, Wei J, Meng WY, Wang N, Wang T, Wang YG. Effects of phased joint intervention on Rho/ROCK expression levels in patients with portal hypertension. Exp Ther Med 2016;12:1618-24. [PMID: 27602079 DOI: 10.3892/etm.2016.3454] [Reference Citation Analysis]
397 Boyer TD. Changing clinical practice with measurements of portal pressure. Hepatology 2004;39:283-5. [DOI: 10.1002/hep.20037] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
398 Berzigotti A, García-pagán J. Prevention of recurrent variceal bleeding. Digestive and Liver Disease 2008;40:337-42. [DOI: 10.1016/j.dld.2007.12.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
399 Kravetz D. Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations. J Clin Gastroenterol. 2007;41 Suppl 3:S318-S322. [PMID: 17975483 DOI: 10.1097/mcg.0b013e318157f0a7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
400 Dell'Era A, de Franchis R, Iannuzzi F. Acute variceal bleeding: pharmacological treatment and primary/secondary prophylaxis. Best Pract Res Clin Gastroenterol. 2008;22:279-294. [PMID: 18346684 DOI: 10.1016/j.bpg.2007.11.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
401 Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol. 2008;48 Suppl 1:S68-S92. [PMID: 18304681 DOI: 10.1016/j.jhep.2008.01.021] [Cited by in Crossref: 190] [Cited by in F6Publishing: 154] [Article Influence: 13.6] [Reference Citation Analysis]
402 Gunnarsdottir SA, Olsson R, Björnsson ES. Characteristics, prognosis and outcome of patients with oesophageal varices in a university hospital in Sweden 1994-1999. Scand J Gastroenterol. 2005;40:1462-1468. [PMID: 16293558 DOI: 10.1080/00365520510023783] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
403 Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology. 2006;44:7-14. [PMID: 16799965 DOI: 10.1002/hep.21258] [Cited by in Crossref: 167] [Cited by in F6Publishing: 138] [Article Influence: 10.4] [Reference Citation Analysis]
404 Bass NM, Yao FY. The Role of the Interventional Radiologist: Transjugular Procedures. Gastrointestinal Endoscopy Clinics of North America 2001;11:131-61. [DOI: 10.1016/s1052-5157(18)30091-6] [Cited by in Crossref: 8] [Article Influence: 0.4] [Reference Citation Analysis]
405 Fernandez-Urien I, Carretero C, Armendariz R, Muñoz-Navas M. Esophageal capsule endoscopy. World J Gastroenterol 2008; 14(34): 5254-5260 [PMID: 18785275 DOI: 10.3748/wjg.14.5254] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
406 Addley J, Tham TC, Cash WJ. Use of portal pressure studies in the management of variceal haemorrhage. World J Gastrointest Endosc 2012; 4(7): 281-289 [PMID: 22816007 DOI: 10.4253/wjge.v4.i7.281] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
407 Shin J, Yu JH, Jin YJ, Yim HJ, Jung YK, Yang JM, Song DS, Kim YS, Kim SG, Kim DJ, Suk KT, Yoon EL, Lee SS, Kim CW, Kim HY, Jang JY, Jeong SW. Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding. Clin Mol Hepatol 2020;26:540-53. [PMID: 32937688 DOI: 10.3350/cmh.2020.0034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
408 Bossen L, Krag A, Vilstrup H, Watson H, Jepsen P. Nonselective β-blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients: Liver Failure/Cirrhosis/Portal Hypertension. Hepatology 2016;63:1968-76. [DOI: 10.1002/hep.28352] [Cited by in Crossref: 71] [Cited by in F6Publishing: 53] [Article Influence: 11.8] [Reference Citation Analysis]
409 Chen TW, Yang ZG, Li X, Wang QL, Qian LL, Wang RR. Evaluation of entire gastric fundic and esophageal varices secondary to posthepatitic cirrhosis: portal venography using 64-row MDCT. Abdom Imaging. 2010;35:1-7. [PMID: 19247703 DOI: 10.1007/s00261-009-9506-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
410 Lo GH. The role of endoscopy in secondary prophylaxis of esophageal varices. Clin Liver Dis 2010;14:307-23. [PMID: 20682237 DOI: 10.1016/j.cld.2010.03.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
411 Seo YS, Shah VH. Pathophysiology of portal hypertension and its clinical links. J Clin Exp Hepatol 2011;1:87-93. [PMID: 25755320 DOI: 10.1016/S0973-6883(11)60127-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
412 Lin LL, Du SM, Fu Y, Gu HY, Wang L, Jian ZY, Shen XF, Luo J, Zhang C. Combination therapy versus pharmacotherapy, endoscopic variceal ligation, or the transjugular intrahepatic portosystemic shunt alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized controlled trials. Oncotarget 2017;8:57399-408. [PMID: 28915680 DOI: 10.18632/oncotarget.18143] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
413 Macedo G, Lopes S, Barroso S, Malheiro L, Ferreira A, Campos M, Costa-maia J, de Matos N. Implementation of screening and preventive strategies in liver transplant candidates. Transplantation Proceedings 2003;35:1115. [DOI: 10.1016/s0041-1345(03)00330-0] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
414 de Franchis R. Evaluation and follow-up of patients with cirrhosis and oesophageal varices. J Hepatol. 2003;38:361-363. [PMID: 12586304 DOI: 10.1016/s0168-8278(03)00011-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
415 Tomikawa M, Shimabukuro R, Okita K, Tsutsumi N, Akahoshi T, Hashizume M, Sugimachi K. Propranolol alone may not be acceptable to prevent first esophageal variceal bleeding in Japanese cirrhotic patients: Randomized controlled trial. J Gastroenterol Hepatol 2004;19:576-81. [DOI: 10.1111/j.1440-1746.2003.03331.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
416 Grewal P, Martin P. Pretransplant management of the cirrhotic patient. Clin Liver Dis 2007;11:431-49. [PMID: 17606216 DOI: 10.1016/j.cld.2007.04.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
417 Shi L, Zhang X, Li J, Bai X. Favorable Effects of Endoscopic Ligation Combined with Drugs on Rebleeding and Mortality in Cirrhotic Patients: A Network Meta-Analysis. Dig Dis 2018;36:136-49. [PMID: 29161702 DOI: 10.1159/000484082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
418 Arguedas MR, McGuire BM, Fallon MB, Abrams GA. The use of screening and preventive therapies for gastroesophageal varices in patients referred for evaluation of orthotopic liver transplantation. Am J Gastroenterol. 2001;96:833-837. [PMID: 11280560 DOI: 10.1111/j.1572-0241.2001.03627.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
419 Nusrat S, Khan MS, Fazili J, Madhoun MF. Cirrhosis and its complications: Evidence based treatment. World J Gastroenterol 2014; 20(18): 5442-5460 [PMID: 24833875 DOI: 10.3748/wjg.v20.i18.5442] [Cited by in CrossRef: 93] [Cited by in F6Publishing: 81] [Article Influence: 11.6] [Reference Citation Analysis]
420 Branch-Elliman W, Perumalswami P, Factor SH, Sled SM, Flamm SL. Rates of recurrent variceal bleeding are low with modern esophageal banding strategies: a retrospective cohort study. Scand J Gastroenterol. 2015;50:1059-1067. [PMID: 25865440 DOI: 10.3109/00365521.2015.1027263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
421 Kim DH, Park JY. Prevention and management of variceal hemorrhage. Int J Hepatol 2013;2013:434609. [PMID: 23606973 DOI: 10.1155/2013/434609] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
422 Abraldes JG, Bosch J. Novel approaches to treat portal hyper-tension. J Gastroenterol Hepatol. 2002;17:S232-S241. [PMID: 12472942 DOI: 10.1046/j.1440-1746.17.s3.6.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
423 White CM, Kilgore ML. PillCam ESO versus esophagogastro duodenoscopy in esophageal variceal screening: A decision analysis.J Clin Gastroenterol. 2009;43:975-981. [PMID: 19661814 DOI: 10.1097/MCG.0b013e3181a7ed09] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
424 Mustafa MZ, Stanley A. Variceal rebleeding: use of drug therapy and endoscopic band ligation. Expert Review of Gastroenterology & Hepatology 2013;8:179-83. [DOI: 10.1586/17474124.2014.876358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
425 Newby DE, Jalan R. UROTENSIN II: BETTER THAN SOMATOSTATIN FOR PORTAL HYPERTENSION? Hepatology. 2000;31:1201-1202. [PMID: 738222 DOI: 10.1002/hep.510310524] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
426 de Franchis R, Dell’Era A, Iannuzzi F. Diagnosis and treatment of portal hypertension. Dig Liver Dis. 2004;36:787-798. [PMID: 15646423 DOI: 10.1016/j.dld.2004.08.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
427 Yu SK, Kwon OS, Jung HS, Bae KS, Kwon KA, Kim YK, Kim YS, Kim JH. Influence of transforming growth factor-beta1 gene polymorphism at codon 10 on the development of cirrhosis in chronic hepatitis B virus carriers. J Korean Med Sci. 2010;25:564-569. [PMID: 20357999 DOI: 10.3346/jkms.2010.25.4.564] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
428 de la Peña J, Brullet E, Sanchez-hernández E, Rivero M, Vergara M, Martin-lorente JL, Garcia Suárez C. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: A multicenter trial. Hepatology 2005;41:572-8. [DOI: 10.1002/hep.20584] [Cited by in Crossref: 150] [Cited by in F6Publishing: 116] [Article Influence: 8.8] [Reference Citation Analysis]